[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 13686
1. Hori T, Taniguchi K, Kurata M, Nakamura K, Kato K, Ogura Y, Iwasaki M, Okamoto S, Yamakado K, Yagi S, Iida T, Kato T, Saito K, Wang L, Kawarada Y, Uemoto S: Carcinoembryonic antigen-producing adrenal adenoma resected using combined lateral and anterior transperitoneal laparoscopic surgery. World J Gastroenterol; 2007 Dec 7;13(45):6094-7
MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carcinoembryonic antigen-producing adrenal adenoma resected using combined lateral and anterior transperitoneal laparoscopic surgery.
  • Fluorodeoxyglucose positron emission tomography showed increased uptake in the adrenal tumor only, with a maximum standardized uptake value of 2.8.
  • Selective venography and blood sampling revealed that the concentrations of cortisol, catecholamines and CEA were significantly elevated in the vein draining the tumor.
  • A diagnosis of CEA-producing benign adenoma was made.
  • Histopathological examination revealed a benign adenoma.
  • We present, to the best of our knowledge, the first case of CEA-producing adrenal adenoma, along with a review of the relevant literature, and discuss our laparoscopic surgery techniques.
  • [MeSH-major] Adenoma / blood. Adrenal Gland Neoplasms / blood. Carcinoembryonic Antigen / blood. Laparoscopy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18023107.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen
  • [Number-of-references] 11
  • [Other-IDs] NLM/ PMC4250898
  •  go-up   go-down


2. Garg P, Daga SR: Parathyroid adenoma. Indian Pediatr; 2006 Aug;43(8):747-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parathyroid adenoma.
  • [MeSH-major] Adenoma / diagnosis. Hyperparathyroidism / diagnosis. Parathyroid Glands / pathology. Parathyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16951447.001).
  • [ISSN] 0019-6061
  • [Journal-full-title] Indian pediatrics
  • [ISO-abbreviation] Indian Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] India
  •  go-up   go-down


3. Balasanthiran A, Sandler B, Amonoo-Kuofi K, Swamy R, Kaniyur S, Kaplan F: Sarcoid granulomas in the parathyroid gland - a case of dual pathology: hypercalcaemia due to a parathyroid adenoma and coexistent sarcoidosis with granulomas located within the parathyroid adenoma and thyroid gland. Endocr J; 2010;57(7):603-7
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcoid granulomas in the parathyroid gland - a case of dual pathology: hypercalcaemia due to a parathyroid adenoma and coexistent sarcoidosis with granulomas located within the parathyroid adenoma and thyroid gland.
  • Parathyroid imaging was then requested and an adenoma was identified.
  • Surprisingly, surgery revealed the coexistence of a parathyroid adenoma with the unexpected finding of sarcoid granulomas within the parathyroid and thyroid glands.
  • [MeSH-major] Adenoma / complications. Granuloma / complications. Hypercalcemia / etiology. Parathyroid Diseases / complications. Parathyroid Neoplasms / complications. Sarcoidosis / complications. Thyroid Neoplasms / complications
  • [MeSH-minor] Aged. Female. Humans. Neoplasms, Multiple Primary / complications. Neoplasms, Multiple Primary / surgery. Parathyroid Glands / pathology. Parathyroid Glands / surgery. Parathyroidectomy. Thyroid Gland / pathology


Advertisement
4. Tretiakova MS, Hart J, Shabani-Rad MT, Zhang J, Gao ZH: Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry. Mod Pathol; 2009 Aug;22(8):1113-20
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distinction of hepatocellular adenoma from hepatocellular carcinoma with and without cirrhosis using E-cadherin and matrix metalloproteinase immunohistochemistry.
  • We studied the tumor cell expression patterns of E-cadherin and matrix metalloproteinase-1, -2, -7, and -9 in a tissue microarray composed of 20 normal livers, 10 hepatocellular adenomas, 43 hepatocellular carcinomas with cirrhosis and 33 hepatocellular carcinomas without cirrhosis.
  • Hepatocellular adenoma was characterized by the complete absence of matrix metalloproteinase-7 expression; hepatocellular carcinoma with cirrhosis was characterized by a significantly low expression of E-cadherin; and hepatocellular carcinoma without cirrhosis was characterized by low matrix metalloproteinase-9 expression.
  • The staining intensity score of E-cadherin=3, matrix a metalloproteinase-7<1, and matrix metalloproteinase-9>or=2 can be used as the diagnostic criteria for hepatocellular adenoma and for distinguishing hepatocellular adenoma from normal, hepatocellular carcinoma with cirrhosis, and hepatocellular carcinoma without cirrhosis.
  • [MeSH-major] Adenoma, Liver Cell / diagnosis. Cadherins / biosynthesis. Carcinoma, Hepatocellular / diagnosis. Liver Cirrhosis / pathology. Liver Neoplasms / pathology. Matrix Metalloproteinases / biosynthesis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Gene Expression. Gene Expression Profiling. Humans. Immunohistochemistry. Male. Matrix Metalloproteinase 1 / biosynthesis. Matrix Metalloproteinase 1 / genetics. Matrix Metalloproteinase 2 / biosynthesis. Matrix Metalloproteinase 2 / genetics. Matrix Metalloproteinase 7 / biosynthesis. Matrix Metalloproteinase 7 / genetics. Matrix Metalloproteinase 9 / biosynthesis. Matrix Metalloproteinase 9 / genetics. Middle Aged. Tissue Array Analysis

  • MedlinePlus Health Information. consumer health - Cirrhosis.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19465902.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cadherins; EC 3.4.24.- / Matrix Metalloproteinases; EC 3.4.24.23 / Matrix Metalloproteinase 7; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.35 / Matrix Metalloproteinase 9; EC 3.4.24.7 / Matrix Metalloproteinase 1
  •  go-up   go-down


5. Bergheim I, Bode C, Parlesak A: Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma. BMC Gastroenterol; 2005;5:34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
  • To estimate the role of cytochrome P450 in carcinogenesis of the colon, expression patterns and protein levels of four representative CYPs (CYP2C, CYP2E1, CYP3A4 and CYP3A5) were determined in colon mucosa of normal and adenomatous colonic tissue of patients with adenomas and disease-free controls.
  • METHODS: Expression of CYP2C, CYP2E1, CYP3A4, and CYP3A5 in colon mucosa of normal and adenomatous colonic tissue of patients with adenoma and disease-free controls was determined by RT-PCR.
  • RESULTS: With the exception of CYP3A5, expression of CYP mRNA was similar among groups and tissues (e.g. normal colon mucosa and adenoma).
  • CYP3A5 mRNA expression was significantly higher in adenoma in comparison to normal tissue of patients with adenoma (approximately 48%).
  • When comparing protein concentrations of CYPs measured in adenomas with neighboring normal colonic mucosa no differences were found.
  • However, in normal tissue of patients with adenomas, protein levels of CYP2C8, CYP3A4 and CYP3A5, but not that of CYP2E1, were significantly lower than in biopsies obtained from disease-free controls.
  • Specifically, in normal colonic mucosa of patients protein concentrations of CYP2C8, CYP3A4, and CYP3A5 were approximately 86%, approximately 69%, and approximately 54%, respectively, lower than in disease-free controls.
  • CYP2C8, CYP3A4 and CYP3A5) in colon mucosa might contribute to the development of neoplasia in the colon.
  • [MeSH-major] Adenoma / enzymology. Colon / enzymology. Colonic Neoplasms / enzymology. Cytochrome P-450 CYP2E1 / metabolism. Cytochrome P-450 Enzyme System / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Biochem Biophys. 2000 Apr 1;376(1):180-90 [10729204.001]
  • [Cites] Virchows Arch. 1999 May;434(5):401-11 [10389623.001]
  • [Cites] Arch Biochem Biophys. 2002 Feb 1;398(1):109-17 [11811955.001]
  • [Cites] Biochem Biophys Res Commun. 2002 Nov 15;298(5):687-92 [12419308.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 2003;43:149-73 [12171978.001]
  • [Cites] J Pharm Pharmacol. 2003 Jan;55(1):59-66 [12625868.001]
  • [Cites] Front Biosci. 2004 May 1;9:1967-76 [14977602.001]
  • [Cites] Curr Drug Metab. 2004 Jun;5(3):211-24 [15180491.001]
  • [Cites] Anal Biochem. 1976 May 7;72:248-54 [942051.001]
  • [Cites] Gut. 1991 Apr;32(4):408-12 [1902809.001]
  • [Cites] Carcinogenesis. 1991 May;12(5):905-9 [2029756.001]
  • [Cites] Mol Cell Biochem. 1991 Mar 27;102(1):61-9 [2052000.001]
  • [Cites] Crit Rev Toxicol. 1991;21(6):407-22 [1801846.001]
  • [Cites] J Biol Chem. 1992 Aug 5;267(22):15765-9 [1639811.001]
  • [Cites] Cancer Res. 1992 Dec 1;52(23):6567-75 [1423302.001]
  • [Cites] Gut. 1993 Sep;34(9):1234-9 [8406161.001]
  • [Cites] Mutat Res. 1993 Nov;290(1):27-33 [7694095.001]
  • [Cites] Anal Biochem. 1993 Sep;213(2):414-21 [8238918.001]
  • [Cites] Biochem Pharmacol. 1994 Jul 5;48(1):59-64 [8043031.001]
  • [Cites] Cancer Chemother Pharmacol. 1994;34(6):497-502 [7923560.001]
  • [Cites] Pharmacogenetics. 1994 Oct;4(5):247-59 [7894497.001]
  • [Cites] Biochem Biophys Res Commun. 1995 May 16;210(2):350-5 [7755610.001]
  • [Cites] Biochem Pharmacol. 1996 Jan 12;51(1):61-9 [8534269.001]
  • [Cites] Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):207-12 [8717162.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Feb 3;231(1):203-5 [9070249.001]
  • [Cites] Drug Metab Dispos. 1999 Jul;27(7):804-9 [10383924.001]
  • [Cites] Curr Drug Metab. 2000 Sep;1(2):107-32 [11465078.001]
  • (PMID = 16281975.001).
  • [ISSN] 1471-230X
  • [Journal-full-title] BMC gastroenterology
  • [ISO-abbreviation] BMC Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / cytochrome P-450 CYP2C subfamily; 9035-51-2 / Cytochrome P-450 Enzyme System; EC 1.14.13.- / Cytochrome P-450 CYP2E1; EC 1.14.13.67 / CYP3A4 protein, human; EC 1.14.14.1 / CYP3A protein, human; EC 1.14.14.1 / CYP3A5 protein, human; EC 1.14.14.1 / Cytochrome P-450 CYP3A
  • [Other-IDs] NLM/ PMC1310537
  •  go-up   go-down


6. Kobayashi T: Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma. Prog Neurol Surg; 2009;22:77-95
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
  • Long-term results of gamma knife radiosurgery for pituitary adenomas are presented and treatment strategies for different adenoma types are discussed.
  • Two hundred and sixty-seven patients with pituitary adenoma have been treated by gamma knife radiosurgery during the past 12 years.
  • There were 131 cases of nonfunctioning and 136 cases of functioning adenomas, in which 71 GH-producing, 33 PRL-producing and 32 ACTH-producing adenomas were included.
  • Micro- and small adenomas could be cured by gamma knife radiosurgery alone.
  • Surgical or chemical debulking was necessary before radiosurgery for a large tumor with extrasellar extension.
  • Nonfunctioning adenomas showed higher control rates than functioning adenomas even with lower dose treatment.
  • Cushing disease showed the best response because of the smallest tumor size with the highest dose treatment.
  • The rate of hormone normalization was also high in Cushing disease but lower in prolactinoma and lowest in acromegaly.
  • High-dose treatment was necessary for functioning adenomas to control tumor growth and oversecretion of hormones.
  • In conclusion, gamma knife radiosurgery was effective and safe for the treatment of pituitary adenomas.
  • However, the treatment strategies should be specific to each adenoma type according to the radiosensitivity, chemosensitivity and biological nature of the tumor.
  • [MeSH-major] ACTH-Secreting Pituitary Adenoma / surgery. Acromegaly / surgery. Adenoma / surgery. Radiosurgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Child. Female. Follow-Up Studies. Growth Hormone-Secreting Pituitary Adenoma / pathology. Growth Hormone-Secreting Pituitary Adenoma / surgery. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Patient Satisfaction. Pituitary ACTH Hypersecretion / pathology. Pituitary ACTH Hypersecretion / surgery. Prolactinoma / pathology. Prolactinoma / surgery. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18948721.001).
  • [ISSN] 0079-6492
  • [Journal-full-title] Progress in neurological surgery
  • [ISO-abbreviation] Prog Neurol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


7. Colović R, Grubor N, Micev M, Ranković V, Matić S, Latincić S: [Serous microcystic adenoma of the head of the pancreas causing an obstructive jaundice]. Vojnosanit Pregl; 2008 Nov;65(11):839-42
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Serous microcystic adenoma of the head of the pancreas causing an obstructive jaundice].
  • BACKGROUND: Serous microcystic adenoma is a rare benign tumor of the exocrine pancreas originating from the ductal system and composed of a large number of small cysts covered by cuboid cells, filled with clear serous fluid and separated with fibrocolagenous stroma.
  • The tumor was removed with pylorus preserving cephalic duodenopancreatectomy (Whipple's procedure modified by Longmire-Traverso).
  • Histology confirmed serous microcystic adenoma of the pancreas.
  • CONCLUSION: Although very rare, serous microcystic adenoma might appear within the head of the pancreas and has to be taken into consideration in differential diagnosis of cystic lesions of the head of the pancreas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19069716.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


8. Moskowitz SI, Hamrahian A, Prayson RA, Pineyro M, Lorenz RR, Weil RJ: Concurrent lymphocytic hypophysitis and pituitary adenoma. Case report and review of the literature. J Neurosurg; 2006 Aug;105(2):309-14
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Concurrent lymphocytic hypophysitis and pituitary adenoma. Case report and review of the literature.
  • The authors report the case of a 43-year-old woman who presented with a 2-month history of galactorrhea and pseudohyperprolactinemia secondary to a 10-mm lesion within an enlarged pituitary gland.
  • Microscopic and immunohistopathological examinations revealed a nonsecreting pituitary adenoma with concurrent lymphocytic adenohypophysitis.
  • This is the first documented case of LyH in the setting of a null-cell pituitary adenoma.
  • The authors review the related literature and outline potential mechanisms for the concurrent development of LyH and a pituitary adenoma.
  • [MeSH-major] Adenoma / complications. Lymphocytosis / complications. Pituitary Diseases / complications. Pituitary Neoplasms / complications
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Galactorrhea / etiology. Galactorrhea / pathology. Galactorrhea / surgery. Humans. Hyperprolactinemia / etiology. Hyperprolactinemia / pathology. Hyperprolactinemia / surgery. Inflammation / complications. Inflammation / diagnosis. Inflammation / pathology. Inflammation / surgery. Magnetic Resonance Imaging. Pituitary Gland / pathology. Sphenoid Bone / surgery


9. Reddy SK, Kishnani PS, Sullivan JA, Koeberl DD, Desai DM, Skinner MA, Rice HE, Clary BM: Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol; 2007 Nov;47(5):658-63
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia.
  • BACKGROUND/AIMS: Because dietary modifications have prolonged the life expectancy of patients with glycogen storage disease type Ia (GSD Ia), the incidence of hepatocellular adenoma (HCA) to carcinoma (HCC) transformation is increasing.
  • GSD Ia patients had greater morbidity (86% vs. 20%) and shorter time to adenoma progression (median 23 months vs. not yet reached) after partial hepatectomy compared to the general population (p<0.05).
  • Three GSD Ia patients underwent liver transplantation 77, 32, and 23 months after adenoma resection.
  • [MeSH-major] Adenoma, Liver Cell / surgery. Biliary Tract Surgical Procedures / statistics & numerical data. Glycogen Storage Disease Type I / complications. Liver / surgery. Liver Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Comorbidity. Disease Progression. Female. Humans. Liver Transplantation / statistics & numerical data. Male. Middle Aged. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Glycogen Storage Disease.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17637480.001).
  • [ISSN] 0168-8278
  • [Journal-full-title] Journal of hepatology
  • [ISO-abbreviation] J. Hepatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


10. Hartman DJ, Maclennan GT: Renal metanephric adenoma. J Urol; 2007 Sep;178(3 Pt 1):1058
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal metanephric adenoma.
  • [MeSH-major] Adenoma / pathology. Kidney Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Urol. 2008 Apr;179(4):1639 [18295802.001]
  • (PMID = 17640685.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Weinreb I, Seethala RR, Hunt JL, Chetty R, Dardick I, Perez-Ordoñez B: Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma. Am J Surg Pathol; 2009 Sep;33(9):1322-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intercalated duct lesions of salivary gland: a morphologic spectrum from hyperplasia to adenoma.
  • Intercalated duct lesions (IDLs) are rare, poorly understood and not well-studied lesions that have been associated with a small number of epithelial-myoepithelial carcinomas (EMC) and basal cell adenomas.
  • To examine the nature of IDLs and their association with salivary gland tumors, we reviewed 34 lesions in 32 patients.
  • The majorities of IDLs were parotid lesions (82%), were small and nodular (average size 3.1 mm) and showed 3 architectural patterns: hyperplasia (20), adenoma (9), and hybrid forms (5).
  • In 59% of cases, IDLs were seen in conjunction with another salivary gland tumor, most commonly basal cell adenoma (8 cases), followed by EMC (3 cases).
  • One case showed a combination of intercalated duct hyperplasia and basal cell adenoma.
  • In summary, IDLs have a variety of patterns ranging from hyperplasia to adenoma with hybrid lesions and share morphologic and immunophenotypic features with normal intercalated ducts.
  • There is an association with basal cell adenomas and EMC, which lends credence to their role as a putative precursor lesion.
  • [MeSH-major] Adenoma / pathology. Salivary Ducts / pathology. Salivary Gland Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Calcium-Binding Proteins / metabolism. Female. Humans. Hyperplasia. Keratins / metabolism. Male. Microfilament Proteins / metabolism. Middle Aged. Muramidase / metabolism. Neoplasms, Multiple Primary. Parotid Gland / metabolism. Parotid Gland / pathology. Parotid Gland / surgery. Receptors, Steroid / metabolism. S100 Proteins / metabolism. Submandibular Gland / metabolism. Submandibular Gland / pathology. Submandibular Gland / surgery. Young Adult

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19542868.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Calcium-Binding Proteins; 0 / Microfilament Proteins; 0 / Receptors, Steroid; 0 / S100 Proteins; 0 / calponin; 68238-35-7 / Keratins; EC 3.2.1.17 / Muramidase
  •  go-up   go-down


12. Okamoto Y, Okamoto F, Yamada S, Honda M, Hiraoka T, Oshika T: Vision-related quality of life after transsphenoidal surgery for pituitary adenoma. Invest Ophthalmol Vis Sci; 2010 Jul;51(7):3405-10
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vision-related quality of life after transsphenoidal surgery for pituitary adenoma.
  • PURPOSE. To use the 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) to evaluate vision-related quality of life (VR-QOL) in patients with pituitary adenoma who undergo transsphenoidal surgery.
  • METHODS. The VFQ-25 was self-administered by 74 patients with pituitary adenoma before and 3 months after surgery.
  • Pre- and postoperative clinical data were collected, including age, sex, tumor type and size, logarithm of minimum angle of resolution best corrected visual acuity (logMAR BCVA), critical flicker fusion frequency, static perimetry scores (mean deviation [MD] and corrected pattern SD [CPSD]), duration of ocular symptoms, and number of systemic comorbidities.
  • Transsphenoidal surgery for pituitary adenoma significantly improved logMAR BCVA and critical fusion flicker frequency in the worse-seeing eye and MD and CPSD scores in both the better- and worse-seeing eyes (P < 0.001).
  • CONCLUSIONS. This study quantitatively demonstrated that transsphenoidal surgery can dramatically improve VR-QOL in pituitary adenoma and that the preoperative VFQ-25 composite score and visual field disturbance in the better-seeing eye are particularly important predictors associated with the postoperative VR-QOL.
  • [MeSH-major] Adenoma / surgery. Ophthalmologic Surgical Procedures. Pituitary Neoplasms / surgery. Quality of Life. Vision, Ocular / physiology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20181847.001).
  • [ISSN] 1552-5783
  • [Journal-full-title] Investigative ophthalmology & visual science
  • [ISO-abbreviation] Invest. Ophthalmol. Vis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Hojo M, Hashimoto N: [Pituitary adenoma]. Nihon Rinsho; 2006 May 28;Suppl 1:159-61
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pituitary adenoma].
  • [MeSH-major] Adenoma. Pituitary Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16776117.001).
  • [ISSN] 0047-1852
  • [Journal-full-title] Nihon rinsho. Japanese journal of clinical medicine
  • [ISO-abbreviation] Nippon Rinsho
  • [Language] jpn
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 10
  •  go-up   go-down


14. Dehesdin D, Guerrier B, Santini J, Zanaret M, Le Clech G: [Parathyroid adenoma]. Ann Otolaryngol Chir Cervicofac; 2008 Apr;125(2):78-84

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Parathyroid adenoma].
  • [MeSH-major] Adenoma / diagnosis. Parathyroid Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18436188.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


15. Harsch IA: [Small adenoma--big effect]. MMW Fortschr Med; 2005 Dec 15;147(51-52):77
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Small adenoma--big effect].
  • [Transliterated title] Kleines Adenom--grosse Wirkung.
  • [MeSH-major] Adenoma / diagnosis. Cushing Syndrome / etiology. Pituitary Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16402722.001).
  • [ISSN] 1438-3276
  • [Journal-full-title] MMW Fortschritte der Medizin
  • [ISO-abbreviation] MMW Fortschr Med
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


16. Mülayim B, Gürakan H, Dagli V, Mülayim S, Aydin O, Akkaya H: Unaware of a giant serous cyst adenoma: a case report. Arch Gynecol Obstet; 2006 Mar;273(6):381-3
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unaware of a giant serous cyst adenoma: a case report.
  • A case of 36-year-old nonmarried virgin woman presenting a giant ovarian serous cyst adenoma weighing 9.5 kg is reported here.
  • The single most common benign ovarian neoplasm is the benign cystic teratoma; however, according to some studies it is serous cyst adenoma.
  • Her pathology report disclosed a 35 x 20 x 16 cm(3) serous cyst adenoma weighing 9.5 kg.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16249904.001).
  • [ISSN] 0932-0067
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Gurey LE, Brook CD, Parnes SM: Pleomorphic adenoma of the infratemporal fossa: case report and literature review. Laryngoscope; 2010;120 Suppl 4:S151
MedlinePlus Health Information. consumer health - Sports Injuries.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic adenoma of the infratemporal fossa: case report and literature review.
  • OBJECTIVES: To describe an unusual location for a common benign salivary gland neoplasm.
  • A complete PubMed search of atypical presentations of pleomorphic adenoma was performed.
  • RESULTS: Pleomorphic adenoma has been reported to arise in such diverse locations as the nasal septum, main stem bronchus, trachea, lacrimal gland and external auditory canal.
  • No cases of pleomorphic adenoma involving the infratemporal fossa have been reported.
  • Malignancies can often have an insidious presentation that is initially referred to other disease entities.
  • Patients with malignancies of this region usually present late in their disease course with invasion into surrounding structures.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Athletic Injuries / complications. Facial Injuries / complications. Skull Neoplasms / pathology. Temporal Bone / pathology

  • MedlinePlus Health Information. consumer health - Facial Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21225749.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


18. Yan QZ, Li HZ, Pan DL: [Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore]. Zhonghua Yi Xue Za Zhi; 2006 Nov 14;86(42):3002-4
Genetic Alliance. consumer health - Hyperaldosteronism.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and strategy therefore].
  • OBJECTIVE: To analyze the causes of delaying diagnosis of primary hyperaldosteronism with adrenal adenoma and discuss corrective strategies.
  • METHODS: The clinical data of 267 patients of primary hyperaldosteronism with adrenal adenoma confirmed by operation 1995 - 2005 were analyzed.
  • Adrenal adenoma was discovered by computed tomography with thin coat screening in 267 patients and by ultrasonography in 151 patients.
  • [MeSH-major] Adrenal Cortex Neoplasms / diagnosis. Adrenocortical Adenoma / diagnosis. Hyperaldosteronism / diagnosis
  • [MeSH-minor] Adult. Aged. Aldosterone / blood. Biomarkers, Tumor / blood. Chymosin / blood. Early Diagnosis. Female. Humans. Hypertension / diagnosis. Hypokalemia / diagnosis. Male. Mass Screening / methods. Middle Aged. Reproducibility of Results. Retrospective Studies. Sensitivity and Specificity. Time Factors. Tomography, X-Ray Computed. Ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17288816.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 4964P6T9RB / Aldosterone; EC 3.4.23.4 / Chymosin
  •  go-up   go-down


19. Ikeda H: Specificity of systemic inflammatory response syndrome during the peri-operative period in patients with GH-secreting adenoma. Cytokine; 2009 Apr;46(1):92-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Specificity of systemic inflammatory response syndrome during the peri-operative period in patients with GH-secreting adenoma.
  • OBJECTIVE: To analyze the differences in systemic inflammatory responses (SIRS) during the peri-operative period following pituitary surgery, patients with pituitary adenomas were studied.
  • METHODS: There were three patient groups: group A consisted of 30 patients with GH-secreting adenoma, group B consisted of 20 age-matched patients with Cushing's disease, and group C consisted of 30 patients with other kinds of pituitary adenoma.
  • CONCLUSION: The inflammatory reaction to surgical trauma is milder in patients with GH-secreting adenomas than in patients with other kinds of pituitary adenoma.
  • [MeSH-minor] Adult. C-Reactive Protein / metabolism. Female. Humans. Interleukin-6 / metabolism. Leukocytes / metabolism. Leukocytosis / blood. Male. Middle Aged. Pituitary Gland / metabolism. Pituitary Hormones / blood

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19264503.001).
  • [ISSN] 1096-0023
  • [Journal-full-title] Cytokine
  • [ISO-abbreviation] Cytokine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Interleukin-6; 0 / Pituitary Hormones; 12629-01-5 / Human Growth Hormone; 9007-41-4 / C-Reactive Protein
  •  go-up   go-down


20. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P: Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis. Mutat Res; 2009 Nov 2;670(1-2):6-14
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gene-smoking interaction on colorectal adenoma and cancer risk: review and meta-analysis.
  • Tobacco smoke has been found to be associated both with colorectal adenoma and cancer development.
  • We found a weak suggestion of an antagonistic effect of mEH3 low or medium metabolizer with smoking on colorectal adenoma risk (pooled P-value for the interaction: 0.02): smokers carriers of mEH3 low or medium metabolizer had slightly lower risk (Odds Ratio; 95% Confidence Interval: 1.6; 1.2-2.1) than smokers with mEH3 high metabolizer (1.8; 1.4-2.4).
  • A non-significant positive interaction between GSTT1 null genotype and smoking was suggested for colorectal adenoma risk.
  • None of the other common genetic polymorphisms involved in tobacco carcinogens metabolism seemed to modify the smoking-related risk of colorectal adenoma or cancer.
  • [MeSH-minor] Adenoma / etiology. Adenoma / genetics. Genetic Predisposition to Disease. Glutathione Transferase / genetics. Humans. Risk

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19589345.001).
  • [ISSN] 0027-5107
  • [Journal-full-title] Mutation research
  • [ISO-abbreviation] Mutat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 2.5.1.18 / Glutathione Transferase
  • [Number-of-references] 64
  •  go-up   go-down


21. Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH: Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin Radiol; 2007 May;62(5):453-62
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI.
  • AIMS: To determine the differential magnetic resonance imaging (MRI) features of pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions.
  • MATERIALS AND METHODS: The MRI images of 64 patients with pituitary adenoma (n=38), craniopharyngioma (n=13), or Rathke cleft cyst (n=13) were retrospectively reviewed by three neuroradiologists.
  • Fisher's exact test applied with Bonferroni correction was used for multiple comparison.
  • RESULTS: A snowman shape, solid characteristics, and homogeneous enhancement of the solid portion were more common in pituitary adenomas (p<0.017).
  • The flowchart yielded diagnostic accuracies as follows: 92.1% in pituitary adenoma; 92.3% in craniopharyngioma; 92.3% in Rathke cleft cyst; and 92.2% overall.
  • [MeSH-major] Adenoma / pathology. Central Nervous System Cysts / pathology. Craniopharyngioma / pathology. Magnetic Resonance Imaging / methods. Pituitary Neoplasms / pathology

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17398271.001).
  • [ISSN] 0009-9260
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


22. Miyazaki T, Yamasaki T, Moritake K, Matsumoto Y, Akiyama Y, Nagai H, Yamamoto Y, Kodama T: Unusual progression of pleomorphic adenoma of the lacrimal gland: case report. Neurol Med Chir (Tokyo); 2005 Aug;45(8):407-10
MedlinePlus Health Information. consumer health - Tears.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual progression of pleomorphic adenoma of the lacrimal gland: case report.
  • The preoperative diagnosis was pleomorphic adenoma with or without malignant transformation, or cavernous angioma.
  • The transcranial route was chosen since tumor invasion to the cranial base was possible.
  • The histological diagnosis was pleomorphic adenoma.
  • Accurate clinical diagnosis of neoplasm in the orbital cavity is important for correct therapeutic management.
  • The present case suggests that pleomorphic adenoma should also be considered in the differential diagnosis.
  • The therapeutic strategy for lacrimal gland tumors remains controversial, so a flexible management approach is required.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Lacrimal Apparatus / pathology. Lacrimal Apparatus Diseases / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Aged. Disease Progression. Exophthalmos / etiology. Exophthalmos / pathology. Exophthalmos / radiography. Female. Humans. Magnetic Resonance Imaging. Neurosurgical Procedures. Orbit / pathology. Orbit / radiography. Orbit / surgery. Pain / etiology. Pain / pathology. Pain / radiography. Retrobulbar Hemorrhage / etiology. Retrobulbar Hemorrhage / pathology. Retrobulbar Hemorrhage / radiography. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16127259.001).
  • [ISSN] 0470-8105
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


23. Horiuchi A, Nakayama Y: Improved colorectal adenoma detection with a transparent retractable extension device. Am J Gastroenterol; 2008 Feb;103(2):341-5
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Improved colorectal adenoma detection with a transparent retractable extension device.
  • We studied the effects of a retractable transparent extension device on adenoma detection rate as well as on intubation and withdrawal times.
  • A subset of patients with colonic adenomas were randomized to repeat colonoscopy with or without a TRE device.
  • Adenoma removal was done at the second colonoscopy.
  • The principal outcome parameters were the cecal intubation time, withdrawal time, and the number, size, and location of adenomas detected.
  • The patients' demographic characteristics, the indications for colonoscopy, the cecal intubation time and withdrawal time, and the proportion of patients with adenomas (29.0%vs 24.1%) (P= 0.11) were similar between the two techniques.
  • The number of adenomas detected with the TRE was significantly higher than that without the extension (205 vs 150) (P= 0.04).
  • Second, 60 patients with adenomas found at colonoscopy without the device were randomized to repeat colonoscopy within 3 months.
  • Hood-assisted colonoscopy revealed 20% more adenomas than the initial procedure compared to a 4% increase without the hood (P= 0.029).
  • CONCLUSIONS: Colonoscopy with a TRE device improved the adenoma detection rate without affecting intubation and withdrawal times.
  • [MeSH-major] Adenoma / diagnosis. Colonoscopes. Colorectal Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Gastroenterol. 2008 Sep;103(9):2401; author reply 2401-2 [18844627.001]
  • (PMID = 18076740.001).
  • [ISSN] 0002-9270
  • [Journal-full-title] The American journal of gastroenterology
  • [ISO-abbreviation] Am. J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


24. Magliulo G, Bertin S: Adenoma of the ceruminous gland. Otolaryngol Head Neck Surg; 2010 Sep;143(3):459-60

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenoma of the ceruminous gland.
  • [MeSH-major] Adenoma / pathology. Cerumen. Ear Canal. Ear Neoplasms / pathology. Sweat Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20723789.001).
  • [ISSN] 1097-6817
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Guthoff M, Schnauder G, Kirchhoff K, Kurth R, Horger M, Müssig K: [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009]. Dtsch Med Wochenschr; 2009 Jul;134(31-32):1582
Genetic Alliance. consumer health - Primary aldosteronism.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Normokalaemic primary aldosteronism due to an aldosterone-producing adrenal adenoma--Case 06/2009].
  • A saline infusion test showed no suppression of the plasma aldosterone concentration, nor did an orthostatic testing show an increase.
  • MRI revealed an adenoma of the right adrenal gland.
  • DIAGNOSIS, TREATMENT AND COURSE: The results were consistent with primary aldosteronism due to an aldosterone-producing adenoma of the adrenal gland.
  • The histological findings confirmed an adenoma of the adrenal gland.
  • [MeSH-major] Adrenal Cortex Neoplasms / diagnosis. Adrenocortical Adenoma / diagnosis. Hyperaldosteronism / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19629922.001).
  • [ISSN] 1439-4413
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; EC 3.4.23.15 / Renin
  •  go-up   go-down


26. Lizardi-Cervera J, Cuéllar-Gamboa L, Motola-Kuba D: Focal nodular hyperplasia and hepatic adenoma: a review. Ann Hepatol; 2006 Jul-Sep;5(3):206-11
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for hepatic adenoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Focal nodular hyperplasia and hepatic adenoma: a review.
  • Focal Nodular Hyperplasia (FNH) and Hepatic Adenoma (HA) are a benign tumors of the liver.
  • This benign liver tumors are relatively rare lesions and are usually unrelated to subjective symptoms.
  • [MeSH-major] Adenoma, Liver Cell / physiopathology. Focal Nodular Hyperplasia / physiopathology. Liver Neoplasms / physiopathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17060885.001).
  • [ISSN] 1665-2681
  • [Journal-full-title] Annals of hepatology
  • [ISO-abbreviation] Ann Hepatol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Mexico
  • [Chemical-registry-number] 0 / Contraceptives, Oral
  • [Number-of-references] 21
  •  go-up   go-down


27. Patel RS, Hughes CW, Fredericks S, Lee CS, Rose B, Gao K, Smith G, Hong A, O'Brien CJ: Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland. Histopathology; 2007 Jul;51(1):21-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.
  • AIMS: To investigate cyclin A expression in pleomorphic adenoma (PA) and carcinoma expleomorphic adenoma (CXPA) of the parotid gland with a view to assessing its potential value as a diagnostic marker for CXPA.
  • [MeSH-major] Adenoma, Pleomorphic / diagnosis. Adenoma, Pleomorphic / metabolism. Cyclin A / metabolism. Parotid Neoplasms / diagnosis. Parotid Neoplasms / metabolism
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Case-Control Studies. Cell Transformation, Neoplastic / pathology. Diagnosis, Differential. Gene Expression Regulation, Neoplastic. Humans. Parotid Gland / metabolism. Parotid Gland / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17593077.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cyclin A
  •  go-up   go-down


28. Yosepovich A, Perelman M, Ayalon S, Papa M, Kopolovic J: Syringomatous adenoma of the nipple: a case report. Pathol Res Pract; 2005;201(5):405-7
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Syringomatous adenoma of the nipple: a case report.
  • We present a case of a 33-year-old woman who underwent excisional breast biopsy due to a left nipple mass.
  • Histological examination revealed the morphologic and immunohistochemical pattern of syringomatous adenoma of the nipple.
  • This is a rare lesion of the breast that can clinically mimic breast carcinoma, but harbors a benign and only locally aggressive course.
  • Awareness of both the clinician and the pathologist for the possibility of diagnosing this tumor in the nipple region is mandatory to avoid mastectomy and lymph node dissection.
  • [MeSH-major] Breast Neoplasms / pathology. Nipples. Sweat Gland Neoplasms / pathology. Syringoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16047951.001).
  • [ISSN] 0344-0338
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Actins
  •  go-up   go-down


29. Alyahya GA, Stenman G, Persson F, Prause JU, Skjødt K, Saunte JP, Heegaard S: Pleomorphic adenoma arising in an accessory lacrimal gland of Wolfring. Ophthalmology; 2006 May;113(5):879-82
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pleomorphic adenoma arising in an accessory lacrimal gland of Wolfring.
  • PURPOSE: To describe a patient with pleomorphic adenoma arising in an accessory lacrimal gland of Wolfring in the lower lid and to illustrate the immunohistochemical and molecular cytogenetics.
  • METHODS: A 62-year-old man presented with a 20-year history of a painless slowly growing mass at the temporal part of the right lower eyelid.
  • Histological, immunohistochemical, and fluorescence in situ hybridization studies of the excised tumor were performed.
  • The tumor was situated beneath an area of a normal accessory lacrimal gland of Wolfring and in close association with normal meibomian glands.
  • Myoepithelial tumor cells in the myxoid stroma reacted strongly with an antibody against glial fibrillary acidic protein, which did not bind to normal lacrimal gland tissue.
  • Tumor cells with both epithelial and myoepithelial morphologies reacted positively for both pleomorphic adenoma gene-1 and high-mobility group A2 proteins.
  • CONCLUSIONS: Pleomorphic adenoma of the accessory lacrimal gland is an exceedingly rare tumor of the ocular adnexa.
  • Glial fibrillary acidic protein seems to be a tumor-associated antigen.
  • Genetically, this case of pleomorphic adenoma arising from an accessory lacrimal gland of Wolfring is identical with those originating from salivary glands.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Eyelid Neoplasms / pathology. Lacrimal Apparatus Diseases / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Humans. Immunoenzyme Techniques. In Situ Hybridization, Fluorescence. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Tears.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16530838.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


30. Zielińska-Kaźmierska B, Sut M: [Adenoma pleomorphum of the parapharyngeal space -- a report of a case]. Otolaryngol Pol; 2005;59(6):861-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Adenoma pleomorphum of the parapharyngeal space -- a report of a case].
  • [Transliterated title] Gruczolak wielopostaciowy przestrzeni przygardłowej prawej--opis przypadku.
  • Aproximately 80% of these tumors are benign lesions.
  • The most often diagnosed is pleomorphic adenoma.
  • The patients with a diagnosis of pleomorphic adenoma of parapharyngeal space are treated either in Laryngological or in Maxillo-Facial Surgery Departments.
  • The authors present a case of the patient treated because of pleomorphic adenoma of parapharyngeal space in the Cranial and Maxillo-Facial Surgery Department of Medical University of Lódź.
  • The size of the tumor required a wide surgical approach to the parapharyngeal space in order to reach its complete and safe removal.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Oropharyngeal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16521452.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


31. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K, Takano Y: Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res; 2007 Jan-Feb;27(1A):259-65
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
  • MATERIALS AND METHODS: Maspin expression was examined on tissue microarrays containing CRAs (n = 119), adjacent adenoma (n = 22), adjacent non-cancerous mucosa (n = 118) and metastases (n = 67) by immunostaining.
  • RESULTS: Maspin expression showed significant increase from colorectal non-cancerous mucosa to adenocarcinoma through adenoma (p < 0.05).
  • Maspin expression correlated negatively with liver metastasis of CRA (p < 0.05), positively with tenascin expression (p < 0.05), but not with tumor size, depth of invasion, local invasion via vessels, lymph node metastasis, differentiation, expression of Ki-67 and p53 or MVD (p > 0.05).
  • CONCLUSION: Up-regulated maspin expression was involved in colorectal adenoma-adenocarcinoma sequence.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Adenoma / metabolism. Colorectal Neoplasms / metabolism. Liver Neoplasms / secondary. Serpins / biosynthesis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Genes, Tumor Suppressor. Humans. Intestinal Mucosa / metabolism. Ki-67 Antigen / biosynthesis. Male. Middle Aged. Neovascularization, Pathologic / metabolism. Tenascin / biosynthesis. Tissue Array Analysis. Up-Regulation

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17352241.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / SERPIN-B5; 0 / Serpins; 0 / Tenascin
  •  go-up   go-down


32. Burri E, Steuerwald M, Cathomas G, Mentha G, Majno P, Rubbia-Brandt L, Meier R: Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver. Eur J Gastroenterol Hepatol; 2006 Apr;18(4):437-41
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hepatocellular carcinoma in a liver-cell adenoma within a non-cirrhotic liver.
  • Liver-cell adenomas are benign lesions of the liver occurring predominantly in young women.
  • We describe the case of a 40-year-old woman in whom work-up for epigastric pain revealed a peptic ulcer and a large hepatic mass.
  • The tumour was surgically removed and a hepatocellular carcinoma arising within a liver-cell adenoma in a non-cirrhotic liver was found.
  • Malignant transformation of liver-cell adenoma has only been reported in a few case reports.
  • [MeSH-major] Adenoma, Liver Cell / pathology. Carcinoma, Hepatocellular / pathology. Liver Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16538118.001).
  • [ISSN] 0954-691X
  • [Journal-full-title] European journal of gastroenterology & hepatology
  • [ISO-abbreviation] Eur J Gastroenterol Hepatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 42
  •  go-up   go-down


33. Freriks K, den Heijer M, Bonenkamp JJ, Biert J, Sweep CG, Hermus AR: [Intraoperative parathyroid hormone measurement in patients with primary hyperparathyroidism; particularly valuable for suspected solitary parathyroid adenoma and re-operation]. Ned Tijdschr Geneeskd; 2008 Jan 5;152(1):28-32
Genetic Alliance. consumer health - Hyperparathyroidism, primary.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intraoperative parathyroid hormone measurement in patients with primary hyperparathyroidism; particularly valuable for suspected solitary parathyroid adenoma and re-operation].
  • METHOD: Evaluation of the value of intraoperative measurement ofPTH in 75 patients (including 19 patients with multiple endocrine neoplasia(MEN)-1 syndrome) who underwent parathyroidectomy in 2001-2005.
  • The success rate was correctly predicted as follows: in subgroups of patients with MEN-1 syndrome, 85%, patients after exclusion of MEN-1, 94%, and patients in whom a solitary adenoma was likely after preoperative localization studies, 97%.
  • In patients without MEN-1 syndrome, in whom a solitary adenoma was likely on the basis of preoperative investigations, it was possible to limit the operation to a unilateral procedure in 87%.
  • CONCLUSION: In the majority of patients with primary hyperparathyroidism, intraoperative PTH-measurement in combination with preoperative imaging studies leads to patients being cured with a unilateral instead of a bilateral operation.
  • [MeSH-major] Adenoma / surgery. Hyperparathyroidism, Primary / blood. Monitoring, Intraoperative / methods. Parathyroid Hormone / blood. Parathyroid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18240759.001).
  • [ISSN] 0028-2162
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Parathyroid Hormone
  •  go-up   go-down


34. Sagan D, Goździuk K: Surgical treatment of mediastinal parathyroid adenoma: rationale for intraoperative parathyroid hormone monitoring. Ann Thorac Surg; 2010 Jun;89(6):1750-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of mediastinal parathyroid adenoma: rationale for intraoperative parathyroid hormone monitoring.
  • However, when the parathyroid adenoma is located deep in the mediastinum, the surgeon often encounters difficulties to localize and completely remove all hyperfunctioning parathyroid tissues.
  • Thus, we hypothesized that patients with mediastinal adenoma differ substantially from cervical cases and require a specific strategy.
  • RESULTS: In 26 patients the adenoma was correctly identified and removed at targeted mediastinal parathyroidectomy.
  • CONCLUSIONS: Mediastinal parathyroid adenoma represents a distinct subset of primary hyperparathyroidism and requires a specific diagnostic and therapeutic approach.
  • [MeSH-major] Adenoma / blood. Adenoma / surgery. Monitoring, Intraoperative. Parathyroid Hormone / blood. Parathyroid Neoplasms / blood. Parathyroid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20494022.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Parathyroid Hormone
  •  go-up   go-down


35. Bukhari MH, Salaria SM, Niaz Z, Muzzafar A, Batool Z, Qureshi GR, Naveed IA, Chaudhry NA: Mutation of p53 in skin papilloma and tubular breast adenoma of albino mice. J Coll Physicians Surg Pak; 2006 Apr;16(4):280-3
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mutation of p53 in skin papilloma and tubular breast adenoma of albino mice.
  • OBJECTIVE: To determine the mutation of p53 in chemically induced carcinogenesis on albino mice in skin papilloma and tubular adenoma breast by immunohistochemistry.
  • Squamous cell papillomas and tubular adenoma breast were selected for this study.
  • RESULTS: All the papillomas showed faint reactivity for immunomarker p53, while tubular adenomas were nonreactive.
  • [MeSH-major] Adenoma / genetics. Biomarkers, Tumor / analysis. Breast Neoplasms / genetics. Genes, p53. Mutation. Papilloma / genetics
  • [MeSH-minor] Animals. Biopsy, Needle. Disease Models, Animal. Female. Gene Expression Regulation, Neoplastic. Immunohistochemistry. Mice. Mice, Inbred Strains. Neoplasms, Experimental. Random Allocation. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16624193.001).
  • [ISSN] 1022-386X
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


36. Salgado LR, Machado MC, Cukiert A, Liberman B, Kanamura CT, Alves VA: Cushing's disease arising from a clinically nonfunctioning pituitary adenoma. Endocr Pathol; 2006;17(2):191-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cushing's disease arising from a clinically nonfunctioning pituitary adenoma.
  • A 49-yr-old woman with a large pituitary tumor leading to visual loss and galactorrhea- amenorrhea was submitted to transcranial pituitary surgery, when a clinically nonfunctioning pituitary adenoma was partially removed.
  • Histopathology and immunohistochemistry confirmed the diagnosis of "non-secreting atypical adenoma."
  • The overall clinical, laboratory, and pathological data suggest a transition from a clinically nonfunctioning to a hypersecreting ACTH-producing tumor.
  • Putative mechanisms of tumor transformation and the possibility of a silent corticotropinoma evolving into clinical Cushing s syndrome are discussed.
  • [MeSH-major] Adenoma / complications. Adenoma / pathology. Pituitary ACTH Hypersecretion / etiology. Pituitary Neoplasms / complications. Pituitary Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17159252.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Ruivo J, Antunes JL: Maffucci syndrome associated with a pituitary adenoma and a probable brainstem tumor. J Neurosurg; 2009 Feb;110(2):363-8
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maffucci syndrome associated with a pituitary adenoma and a probable brainstem tumor.
  • Malignancies are a common feature of Maffucci syndrome, with chondrosarcomas being the most common tumor type.
  • The authors present the first case of Maffucci syndrome associated with a pituitary adenoma and a probable brainstem glioma and review the literature concerning intracranial tumors related to this disease.
  • They report the case of a 35-year-old woman with Marfucci syndrome (diagnosed when she was 22 years old) who presented with complaints of decreased visual acuity and visual field defect.
  • Neuroimaging revealed a pituitary macroadenoma and a suspected brainstem tumor.
  • To the authors' knowledge, including the present case, only 7 cases of Maffucci syndrome associated with glioma and 7 cases associated with pituitary adenoma have been reported in the literature.
  • This report emphasizes that patients with this disease are at a higher risk for primary intracranial tumors and reinforces the concept of the multiplicity of tumors that may arise in this syndrome.

  • Genetic Alliance. consumer health - Maffucci syndrome.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18976063.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 67
  •  go-up   go-down


38. Hennings J, Andreasson S, Botling J, Hägg A, Sundin A, Hellman P: Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism. Langenbecks Arch Surg; 2010 Feb;395(2):133-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.
  • Preoperative indications for surgery included presumed adenoma (aldosterone-producing adenoma (APA)) or in one case unilateral dominance of hyperplasia.
  • RESULTS: Histopathology was classified into adenoma (n = 9), dominant nodule (n = 16), and general hyperplasia without dominating nodules (n = 5), demonstrating a higher frequency of hyperplasia than anticipated.
  • Hypersecretion of aldosterone may be released from a large nodule identified as an adenoma, as well as from a generally hyperplastic gland that has not been identified as such.
  • Nevertheless, surgery for lateralized disease results in good long-term control of BP with less antihypertensive medication.

  • Genetic Alliance. consumer health - Primary aldosteronism.
  • MedlinePlus Health Information. consumer health - Adrenal Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19418066.001).
  • [ISSN] 1435-2451
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 4964P6T9RB / Aldosterone; EC 3.4.23.15 / Renin
  •  go-up   go-down


39. Marcos Ordóñez M, García Lagarto E, Santos Pérez J, Moráis Pérez D: [Carcinoma on pleomorphic adenoma in cervical salivary heteropia. Handling of one case and literature review]. Acta Otorrinolaringol Esp; 2007 Oct;58(8):371-4
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Carcinoma on pleomorphic adenoma in cervical salivary heteropia. Handling of one case and literature review].
  • [Transliterated title] Carcinoma sobre adenoma pleomorfo en heterotopia salival cervical. Manejo de un caso y revisión de la literatura.
  • The co-existence of carcinoma expleomorphic adenoma in a salivary heterotopia in the upper third of the neck can be considered unusual.
  • We present an infrequent and clinically unsuspected case of carcinoma expleomorphic adenoma in the upper third of the neck and independent of the salivary glands.
  • [MeSH-major] Adenoma, Pleomorphic / complications. Adenoma, Pleomorphic / pathology. Carcinoma / complications. Carcinoma / pathology. Choristoma / complications. Choristoma / pathology. Salivary Gland Neoplasms / complications. Salivary Gland Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17949666.001).
  • [ISSN] 0001-6519
  • [Journal-full-title] Acta otorrinolaringológica española
  • [ISO-abbreviation] Acta Otorrinolaringol Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 12
  •  go-up   go-down


40. Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M: The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma. Exp Oncol; 2006 Mar;28(1):70-4
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
  • AIM: Expression of thyroid peroxidase (TPO) in the thyroid gland tissue is well known as a sensitive marker of the thyroid malignancy.
  • We have evaluated immunohistochemical assay of TPO for distinguishing follicular thyroid carcinoma from follicular adenoma.
  • MATERIALS AND METHODS: Sections of formalin-fixed tissues obtained from 92 patients with thyroid tumors (52 follicular carcinomas and 40 follicular adenomas including the Hurthle cell type) were analyzed using a monoclonal antibody (TPO mAb 47) and the avidin-biotin peroxidase complex immunohistochemical technique.
  • Lesions with staining of more than 80% of the follicular cells/specimen were considered benign, while less than 80% were considered malignant.
  • RESULTS: TPO immunostaining correlated with the histopathological diagnosis in 24/40 cases of follicular adenomas and 41/52 cases of follicular carcinomas, giving a specificity of 60% and a sensitivity of 79%.
  • CONCLUSION: These results suggest that immunohistochemical assay of TPO expression has limited value for the differential diagnosis of follicular thyroid carcinoma from thyroid follicular adenoma.
  • [MeSH-major] Adenocarcinoma, Follicular / pathology. Adenoma / pathology. Iodide Peroxidase / metabolism. Thyroid Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Diagnosis, Differential. Humans. Immunohistochemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16614712.001).
  • [ISSN] 1812-9269
  • [Journal-full-title] Experimental oncology
  • [ISO-abbreviation] Exp. Oncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ukraine
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 1.11.1.8 / Iodide Peroxidase
  •  go-up   go-down


41. Cuthbertson DJ, Ritchie D, Crooks D, Main G, Smith C, Vora J, Eljamel MS, Leese GP: Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma. Endocr J; 2008 Aug;55(4):729-35
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma.
  • Lymphocytic Hypophysitis (LH) is a rare and previously under-recognised disorder, most commonly affecting young females in the post-partum period.
  • It presents clinically with symptoms and signs related to either a pituitary mass or hypopituitarism, frequently mimicking a pituitary adenoma; the diagnosis of LH can only be made histologically with the presence of a dense lymphocytic infiltration usually confined to the anterior pituitary.
  • We present two case histories of patients who presented with symptoms suggestive of a functioning pituitary adenoma who also had concomitant LH confirmed histologically.
  • In both cases a joint diagnosis of a functioning pituitary adenoma with LH was made.
  • [MeSH-major] Adenoma / complications. Pituitary Diseases / complications. Pituitary Neoplasms / complications

  • Genetic Alliance. consumer health - Lymphocytic hypophysitis.
  • MedlinePlus Health Information. consumer health - Pituitary Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18497455.001).
  • [ISSN] 1348-4540
  • [Journal-full-title] Endocrine journal
  • [ISO-abbreviation] Endocr. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


42. Furuse C, Miguita L, Rosa AC, Soares AB, Martinez EF, Altemani A, de Araújo VC: Study of growth factors and receptors in carcinoma ex pleomorphic adenoma. J Oral Pathol Med; 2010 Aug 1;39(7):540-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Study of growth factors and receptors in carcinoma ex pleomorphic adenoma.
  • Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor derived from a pre-existing pleomorphic adenoma.
  • Slides were qualitatively and semi-quantitatively evaluated according to the percentage of stained tumor cells from 0 to 3 (0 = less than 10%; 1 = 10-25%; 2 = 25-50%; 3 = more than 50% of cells).
  • Malignant epithelial cells starting with in situ areas showed stronger expression than luminal cells of pleomorphic adenoma for all antibodies.
  • Altogether this data infers that these factors may contribute to cell proliferation during initial phases of the tumor.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma, Pleomorphic / pathology. Intercellular Signaling Peptides and Proteins / analysis. Parotid Neoplasms / pathology. Receptors, Growth Factor / analysis
  • [MeSH-minor] Adult. Aged. Carcinoma in Situ / pathology. Cell Proliferation. Coloring Agents. Disease Progression. Epithelial Cells / pathology. Female. Fibroblast Growth Factors / analysis. Hepatocyte Growth Factor / analysis. Humans. Male. Middle Aged. Neoplasm Invasiveness. Protein-Serine-Threonine Kinases / analysis. Proto-Oncogene Proteins c-met / analysis. Receptor, Epidermal Growth Factor / analysis. Receptor, Fibroblast Growth Factor, Type 1 / analysis. Receptor, Fibroblast Growth Factor, Type 2 / analysis. Receptor, IGF Type 1 / analysis. Receptors, Transforming Growth Factor beta / analysis. Submandibular Gland Neoplasms / pathology. Transforming Growth Factor beta1 / analysis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20149060.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Intercellular Signaling Peptides and Proteins; 0 / Receptors, Growth Factor; 0 / Receptors, Transforming Growth Factor beta; 0 / Transforming Growth Factor beta1; 62031-54-3 / Fibroblast Growth Factors; 67256-21-7 / Hepatocyte Growth Factor; EC 2.7.10.1 / FGFR1 protein, human; EC 2.7.10.1 / FGFR2 protein, human; EC 2.7.10.1 / Proto-Oncogene Proteins c-met; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 2.7.10.1 / Receptor, Fibroblast Growth Factor, Type 1; EC 2.7.10.1 / Receptor, Fibroblast Growth Factor, Type 2; EC 2.7.10.1 / Receptor, IGF Type 1; EC 2.7.11.1 / Protein-Serine-Threonine Kinases; EC 2.7.11.30 / transforming growth factor-beta type II receptor
  •  go-up   go-down


43. McCluggage WG, Harley I, Houghton JP, Geyer FC, MacKay A, Reis-Filho JS: Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome. J Clin Pathol; 2010 Oct;63(10):935-41
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome.
  • The carcinoma contained two morphologically distinct and spatially separate components, one comprising typical well differentiated adenoma malignum and the other a moderately differentiated neoplasm, in keeping with gastric type adenocarcinoma.
  • It is believed that the component of gastric type adenocarcinoma arose through a process of dedifferentiation within adenoma malignum and we provide circumstantial molecular evidence in support of the interpretation that both components may be clonally related in that they displayed an extra copy of chromosome 7.
  • This raises the possibility of a relationship between these two uncommon types of cervical adenocarcinoma, both of which are thought to exhibit gastric differentiation.
  • [MeSH-major] Adenocarcinoma / pathology. Mixed Tumor, Malignant / pathology. Peutz-Jeghers Syndrome / pathology. Uterine Cervical Neoplasms / pathology

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • MedlinePlus Health Information. consumer health - Cervical Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20876329.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


44. Yamaji T, Iwasaki M, Sasazuki S, Sakamoto H, Yoshida T, Tsugane S: Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev; 2009 Jan;18(1):267-74
Hazardous Substances Data Bank. FOLIC ACID .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Methionine synthase A2756G polymorphism interacts with alcohol and folate intake to influence the risk of colorectal adenoma.
  • We therefore hypothesized that minor allele carriers possess a decreased risk of colorectal adenoma, and examined this hypothesis in a case-control study of colorectal adenoma in Japan involving 723 cases and 670 controls.
  • An unconditional logistic regression model was used to estimate odds ratios (OR) and their 95% confidence intervals (95% CI) for colorectal adenoma after adjustment for potential confounders.
  • The G allele may confer protection against colorectal adenoma in the presence of a considerably good folate status.
  • [MeSH-major] 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase / genetics. Adenoma / genetics. Alcohol Drinking / adverse effects. Colorectal Neoplasms / genetics. Folic Acid / blood. Polymorphism, Genetic

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Folic Acid.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19124508.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 935E97BOY8 / Folic Acid; EC 2.1.1.13 / 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
  •  go-up   go-down


45. Yeşilkaya E, Cinaz P, Bideci A, Camurdan O, Demirel F, Demircan S: Hungry bone syndrome after parathyroidectomy caused by an ectopic parathyroid adenoma. J Bone Miner Metab; 2009;27(1):101-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hungry bone syndrome after parathyroidectomy caused by an ectopic parathyroid adenoma.
  • Herein, we report a 12-year-old girl who was diagnosed to have an ectopic parathyroid adenoma, and HBS was observed in the postsurgical follow-up.
  • [MeSH-minor] Child. Female. Humans. Syndrome. Thymus Gland / pathology. Thymus Gland / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19057842.001).
  • [ISSN] 0914-8779
  • [Journal-full-title] Journal of bone and mineral metabolism
  • [ISO-abbreviation] J. Bone Miner. Metab.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


46. Kim MS, Kim SK, Kim SI, Kim YS, Jeong HJ: Ureteral nephrogenic adenoma in a renal allograft patient. Int J Urol; 2008 Feb;15(2):178-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ureteral nephrogenic adenoma in a renal allograft patient.
  • Both lesions were suspected for tumors, but they showed a ureteral nephrogenic adenoma and a renal hemorrhagic simple cyst.
  • [MeSH-major] Adenoma / diagnosis. Cysts / diagnosis. Hematuria / etiology. Kidney Diseases / diagnosis. Ureteral Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18269460.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


47. Ricchetti T, Paci M, Cavazza A, Ferrari G, Annessi V, De Franco S, Sgarbi G: A case of metastatic epithelioid angiosarcoma in the lamina propria of a sigmoid tubulovillous adenoma. Tumori; 2005 Mar-Apr;91(2):210-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of metastatic epithelioid angiosarcoma in the lamina propria of a sigmoid tubulovillous adenoma.
  • Epithelioid angiosarcoma is an extremely rare tumor.
  • It is generally a secondary tumor and the preferred sites of such metastases are the heart, pericardium, lung, breast, liver, spleen, bone, and brain.
  • The prognosis of this neoplasm is extremely poor.
  • We report a case of epithelioid angiosarcoma with multiple bilateral lung infiltration, bone metastasis, and metastasis of the lamina propria of a tubulovillous adenoma of the colon.
  • [MeSH-major] Adenoma / pathology. Basement Membrane / pathology. Epithelioid Cells / pathology. Hemangiosarcoma / pathology. Hemangiosarcoma / secretion. Sigmoid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15948556.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antigens, CD31
  •  go-up   go-down


48. Bhatoe HS, Kotwal N, Badwal S: Clival pituitary adenoma with acromegaly: case report and review of literature. Skull Base; 2007 Jul;17(4):265-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clival pituitary adenoma with acromegaly: case report and review of literature.
  • Some ectopic cell rests can become adenomatous.
  • Rarely, these cell rests in the clivus can be the site of formation of adenoma.
  • Trans-sphenoidal excision was done and immunohistochemistry revealed the tumor to be a growth hormone-secreting tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Neurochir (Wien). 2002 Nov;144(11):1221-4 [12434179.001]
  • [Cites] Acta Neuropathol. 1999 Sep;98(3):262-72 [10483784.001]
  • [Cites] Neurosurgery. 1989 Feb;24(2):279-82 [2918981.001]
  • [Cites] J Clin Endocrinol Metab. 1986 May;62(5):1065-9 [3958123.001]
  • [Cites] Australas Radiol. 1970 Aug;14(3):241-7 [5477195.001]
  • [Cites] Am J Surg Pathol. 1995 Aug;19(8):900-3 [7611536.001]
  • [Cites] Ultrastruct Pathol. 1993 Nov-Dec;17(6):637-42 [8122329.001]
  • [Cites] Otolaryngol Head Neck Surg. 1993 Feb;108(2):178-83 [8441545.001]
  • [Cites] Radiat Med. 1996 Jul-Aug;14(4):189-91 [8916261.001]
  • [Cites] Acta Chir Belg. 1998 Jan-Feb;98(1):10-3 [9538914.001]
  • (PMID = 18174927.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2039716
  • [Keywords] NOTNLM ; Acromegaly / clivus / pituitary tumor
  •  go-up   go-down


49. Aliyev A, Kabasakal L, Simsek O, Paksoy M, Halac M, Uslu I: Ectopic parathyroid adenoma localized with MIBI scintigraphy and excised with guide of macroaggregated human serum albumin injection. Clin Nucl Med; 2010 Mar;35(3):151-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ectopic parathyroid adenoma localized with MIBI scintigraphy and excised with guide of macroaggregated human serum albumin injection.
  • Most commonly primary hyperparathyroidism is caused by a parathyroid adenoma.
  • Ectopic parathyroid adenomas are rare, but they can complicate the surgical treatment and have an increased morbidity and poorer success rate.
  • In this report, we investigated the usefulness of the radio-guided occult lesion localization technique in the identification of ectopic parathyroid adenomas.
  • We describe the case of a 66-year-old woman who was diagnosed to be hypercalcemic.
  • Tc-99m methoxy-isobutyl-isonitrile scintigraphy identified an ectopic parathyroid adenoma.
  • Careful dissection was then carried out and an enlarged ectopic parathyroid gland was removed.
  • In conclusion, the preoperative imaging of an ectopic parathyroid adenoma and the excision of this tissue with radioguided occult lesion localization technique can open up a new era of minimally invasive parathyroid surgery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20173443.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Serum Albumin; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


50. Park S, Kim SW, Lee BL, Jung EJ, Kim WH: Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer. Hepatogastroenterology; 2006 Jan-Feb;53(67):28-32
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer.
  • BACKGROUND/AIMS: Ampullary carcinoma is uncommon but provides a good model for adenoma-carcinoma sequence.
  • During the adenoma-carcinoma transition, the tumor cells should acquire the ability to invade.
  • The E-cadherin-catenin complex connects the adjacent epithelial cells at the zona adherens, and this adhesion interferes with the tumor cell invasion.
  • Forty-nine (44.1%) cases were associated with adenomatous component.
  • RESULTS: Expressional loss of E-cadherin was detected in 3 (6.1%) adenomas and 73 (65.8%) carcinomas, and the expressional loss was significantly associated with tumor cell differentiation (p<0.05) and survival (p<0.05) in carcinoma.
  • In beta-catenin immunostaining, 4 (8.2%) adenomas and 45 (40.5%) carcinomas showed abnormal staining patterns either as nuclear staining or as a loss of membrane staining.
  • CONCLUSIONS: Alteration of E-cadherin and beta-catenin is a late event during the adenoma-carcinoma sequence in ampullary neoplasms, and the loss of membranous expression of both E-cadherin and beta-catenin is closely correlated with less differentiated histology and poor prognosis.
  • [MeSH-major] Adenoma / metabolism. Adenoma / pathology. Ampulla of Vater. Cadherins / biosynthesis. Carcinoma / metabolism. Carcinoma / pathology. Common Bile Duct Neoplasms / metabolism. Common Bile Duct Neoplasms / pathology. beta Catenin / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16506371.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Cadherins; 0 / beta Catenin
  •  go-up   go-down


51. Chen AM, Garcia J, Bucci MK, Quivey JM, Eisele DW: Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy. Int J Radiat Oncol Biol Phys; 2006 Nov 15;66(4):1031-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent pleomorphic adenoma of the parotid gland: long-term outcome of patients treated with radiation therapy.
  • PURPOSE: To evaluate the role of radiation therapy in the management of recurrent pleomorphic adenoma of the parotid gland.
  • METHODS AND MATERIALS: Between 1960 and 2004, 34 patients were treated with postoperative radiation therapy for recurrent pleomorphic adenoma of the parotid gland to a median dose of 5000 cGy (range, 4,500-6,000 cGy).
  • Gross total resection at the time of surgery before radiation was achieved in 30 patients (88%), and histologic analysis demonstrated multifocal disease in 16 patients (47%).
  • CONCLUSION: The use of postoperative radiation therapy leads to excellent long-term local control for the treatment of recurrent pleomorphic adenoma with acceptable late toxicity.
  • [MeSH-major] Adenoma / radiotherapy. Adenoma / surgery. Neoplasm Recurrence, Local / radiotherapy. Parotid Neoplasms / radiotherapy. Parotid Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17145531.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Chaychi L, Chaidarun S, Golding A, Kinlaw WB, Memoli V, Siegel A: Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement. Endocr Pract; 2010 May-Jun;16(3):463-7
MedlinePlus Health Information. consumer health - Sarcoidosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvement.
  • OBJECTIVE: To describe a patient presenting with the rare findings of synchronous parathyroid adenoma and parathyroid sarcoidosis.
  • METHODS: We describe the clinical history, physical examination findings, laboratory values, imaging findings, and pathologic data of a man who developed recurrent severe hypercalcemia after successful parathyroidectomy.
  • RESULTS: A 67-year-old man had the following initial blood test results: calcium, 11.1 mg/dL (reference range, 8.5-10.6 mg/dL); albumin 4.0 g/dL (reference range, 3.2- 5.2 g/dL); intact parathyroid hormone, 166 pg/mL (reference range, 10-69 pg/mL); creatinine, 1.9 mg/dL; 25-hydroxyvitamin D, 15 ng/mL (reference range, 30-80 ng/mL); and 1,25-dihydroxyvitamin D, 44 pg/mL (reference range, 16-72 pg/mL).
  • Pathologic examination of the resected gland confirmed the diagnosis of parathyroid adenoma, and subsequent review disclosed the presence of noncaseating granulomas within the adenoma.
  • Recurrent hypercalcemia after successful resection of a parathyroid adenoma may require consideration of potential causes other than the initial diagnosis.

  • Genetic Alliance. consumer health - Sarcoidosis.
  • MedlinePlus Health Information. consumer health - Parathyroid Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20061287.001).
  • [ISSN] 1934-2403
  • [Journal-full-title] Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • [ISO-abbreviation] Endocr Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


53. Jung JT, Lee CH, You SS, Ha HK, Bae JS, Kwon JG, Kim EY, Kim HG, Cho CH, Shin IH: [Grading of histology, expression of apoptosis and cell proliferation in gastric mucosa adjacent to gastric adenoma or adenocarcinoma]. Korean J Gastroenterol; 2005 Oct;46(4):269-75
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Grading of histology, expression of apoptosis and cell proliferation in gastric mucosa adjacent to gastric adenoma or adenocarcinoma].
  • BACKGROUND/AIMS: Helicobacter pylori (H. pylori) infection can lead to gastric adenoma and carcinoma through atrophic gastritis and intestinal metaplasia.
  • We tried to investigate H. pylori infection rate, grade of gastritis, environmental risk factors, expression rate of apoptosis and cell proliferation in mucosa adjacent to tumor, and we also tried to find significant factors associated with gastric carcinogenesis.
  • METHODS: Endoscopically diagnosed twenty cases of intestinal type gastric carcinoma, 20 cases of gastric adenoma, and 40 cases of control (normal or gastritis) were enrolled. H. pylori infection rate, histologic grading, apoptosis and immunohistochemical stain (Ki-67 and p53) to check mucosal proliferation were done in endoscopically biopsied tissues at antrum and body at least 2 cm apart from adenoma or carcinoma.
  • In the multivariate analysis, only atrophy of gland was a significant risk factor for adenoma compared to control group (OR 3.7).
  • Degree of mucosal proliferation and apoptosis in gastric mucosa adjacent to tumor are not significantly different in three groups.
  • [MeSH-major] Adenocarcinoma / pathology. Adenoma / pathology. Apoptosis. Cell Proliferation. Gastric Mucosa / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16247270.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Korea (South)
  •  go-up   go-down


54. Katori H, Nozawa A, Tsukuda M: Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma. Auris Nasus Larynx; 2007 Mar;34(1):79-84
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
  • OBJECTIVES: In the present study, we attempted to identify cyclooxygenase-2 (COX-2) expression and Ki-67 index in carcinoma ex-pleomorphic adenoma (Ca ex-PA) using quantitative immunohistochemical analysis and to compare the benign component of the neoplasia.
  • RESULTS: In the immunohistochemical analysis of COX-2 and Ki-67 index, significant increase was observed in Ca ex-PA, especially with adenocarcinoma, compared to pleomorphic adenoma and sialadenitis.
  • CONCLUSIONS: The data support the hypothesis that increased COX-2 expression is associated with early events in malignant transformation of pleomorphic adenoma.
  • [MeSH-major] Adenoma, Pleomorphic / immunology. Cell Transformation, Neoplastic / metabolism. Cyclooxygenase 2 / immunology. Ki-67 Antigen / immunology. Parotid Neoplasms / immunology. Salivary Gland Neoplasms / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17049779.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies; 0 / Ki-67 Antigen; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


55. Keku TO, Amin A, Galanko J, Martin C, Schliebe B, Sandler RS: Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas. Cancer Epidemiol Biomarkers Prev; 2008 Feb;17(2):306-10
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas.
  • Low apoptosis in the normal rectal mucosa has been associated with colorectal adenomas in cross-sectional studies.
  • It is unknown whether apoptosis can predict the occurrence of new adenomas.
  • We evaluated whether apoptosis at baseline colonoscopy, as well as patient and adenoma characteristics, could predict future occurrence of adenomas.
  • Study subjects were participants in the Diet and Health Study III, a cross-sectional study of adenoma risk factors between August 1998 and March 2000.
  • Apoptosis, number of adenomas, size, and atypia at baseline colonoscopy were evaluated as predictors of new adenomas.
  • At baseline, low apoptosis was significantly associated with increased risk of adenomas (P = 0.0001).
  • Compared with those in the lowest tertile, subjects with high apoptosis were less likely to have an adenoma at follow-up (crude OR, 0.25; 95% CI, 0.09-0.65; adjusted OR, 0.29; 95% CI, 0.08-1.06).
  • Having three or more adenomas at baseline was associated with increased risk of new adenomas (crude OR, 2.46; 95% CI, 1.14-5.31; adjusted OR, 3.74; 95% CI, 1.01-13.83).
  • This study suggests that lower apoptosis is associated with increased risk of future adenoma development.
  • If confirmed in larger studies, apoptosis could potentially be used to identify patients at highest risk for developing new adenomas.

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gut. 1999 Dec;45(6):822-8 [10562579.001]
  • [Cites] N Engl J Med. 2006 Aug 31;355(9):950-2 [16943408.001]
  • [Cites] Gastroenterology. 2001 Apr;120(5):1077-83 [11266371.001]
  • [Cites] Nature. 2001 May 17;411(6835):342-8 [11357141.001]
  • [Cites] BMJ. 2001 Jun 23;322(7301):1538-9 [11420280.001]
  • [Cites] Am J Gastroenterol. 2002 Jun;97(6):1524-9 [12094877.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1770-7 [12454832.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):559-65 [12815003.001]
  • [Cites] Dis Colon Rectum. 2004 Mar;47(3):323-33 [14991494.001]
  • [Cites] Cochrane Database Syst Rev. 2004;(2):CD004079 [15106236.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7 [15184247.001]
  • [Cites] Biol Chem. 2004 Jun;385(6):449-64 [15255176.001]
  • [Cites] Cancer. 1974 Sep;34(3):suppl:819-23 [4854649.001]
  • [Cites] J Cell Biol. 1992 Nov;119(3):493-501 [1400587.001]
  • [Cites] N Engl J Med. 1993 Apr 1;328(13):901-6 [8446136.001]
  • [Cites] Mol Carcinog. 1993;8(4):209-13 [8280368.001]
  • [Cites] Gastroenterology. 1995 Feb;108(2):402-8 [7835580.001]
  • [Cites] Cancer Res. 1995 May 1;55(9):1811-6 [7728743.001]
  • [Cites] J Pathol. 1995 May;176(1):37-44 [7616355.001]
  • [Cites] Gastroenterology. 1995 Sep;109(3):994-8 [7657130.001]
  • [Cites] Cancer Res. 1996 May 15;56(10):2422-7 [8625322.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7950-4 [8755583.001]
  • [Cites] Dig Dis Sci. 1996 Nov;41(11):2238-47 [8943979.001]
  • [Cites] Cancer Res. 1997 Jun 15;57(12):2452-9 [9192825.001]
  • [Cites] Carcinogenesis. 1998 Jan;19(1):87-91 [9472698.001]
  • [Cites] Gastroenterology. 1998 Mar;114(3):441-7 [9496933.001]
  • [Cites] Gastroenterology. 1998 Jul;115(1):13-8 [9649453.001]
  • [Cites] Aust N Z J Surg. 1999 Feb;69(2):88-94 [10030808.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2359-65 [16214917.001]
  • [Cites] Ann N Y Acad Sci. 2005 Nov;1059:41-55 [16382042.001]
  • [Cites] Am J Surg. 2006 Apr;191(4):517-26 [16531147.001]
  • [Cites] Gut. 2001 Feb;48(2):238-46 [11156647.001]
  • (PMID = 18268113.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] ENG
  • [Grant] United States / NIDDK NIH HHS / DK / DK007386-28; United States / NCI NIH HHS / CA / R01 CA044684; United States / NCI NIH HHS / CA / R01 CA044684-17; United States / NCI NIH HHS / CA / K01 CA093654; United States / NIDDK NIH HHS / DK / P30 DK034987-24; United States / NIDDK NIH HHS / DK / P30 DK034987; United States / NCI NIH HHS / CA / K01 CA93654; United States / NIDDK NIH HHS / DK / T35DK007386; United States / NIDDK NIH HHS / DK / T35 DK007386-28; United States / NCI NIH HHS / CA / CA044684-17; United States / NIDDK NIH HHS / DK / DK034987-24; United States / NCI NIH HHS / CA / K01 CA093654-04; United States / NIDDK NIH HHS / DK / T35 DK007386; United States / NCI NIH HHS / CA / CA093654-04; United States / NIDDK NIH HHS / DK / P30 DK34987; United States / NCI NIH HHS / CA / R01 CA44684
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS90219; NLM/ PMC2636570
  •  go-up   go-down


56. Senesse P, Touvier M, Kesse E, Faivre J, Boutron-Ruault MC: Tobacco use and associations of beta-carotene and vitamin intakes with colorectal adenoma risk. J Nutr; 2005 Oct;135(10):2468-72
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tobacco use and associations of beta-carotene and vitamin intakes with colorectal adenoma risk.
  • The effects of vitamins and beta-carotene on the risk of colorectal adenomas have not been fully investigated.
  • Recent data suggest that smoking could modulate the effect of beta-carotene supplements on adenoma recurrence.
  • We investigated the effect of dietary vitamins and beta-carotene on the risk of adenomas, and a potential interaction with smoking status as part of a case-control study of environmental factors associated with the risk of colorectal adenomas and cancers.
  • We compared nutrient intakes in polyp-free controls (n = 427) and adenoma cases (n = 362) globally and using models stratified by smoking status, adjusted for age, sex, BMI, and energy and alcohol intakes.
  • Folate and vitamins C and B-6 were inversely related to adenoma risk (P for trend = 0.005, 0.03, and 0.02, respectively), whereas vitamin D tended to be inversely associated with risk (P for trend = 0.05).
  • In nonsmokers, beta-carotene was inversely associated with adenoma risk, especially that of colon adenomas [odds ratios (ORs) in low vs. high consumers and 95% CI 0.4 (0.2-0.9)], whereas in past or current smokers, beta-carotene was associated with a nonsignificant (P for trend = 0.19) increase in the risk of colon adenomas [corresponding OR = 1.9 (95% CI = 0.9-4.1)].
  • [MeSH-major] Adenoma / epidemiology. Colorectal Neoplasms / epidemiology. Smoking / epidemiology. Vitamins / administration & dosage. beta Carotene / administration & dosage

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • Hazardous Substances Data Bank. BETA-CAROTENE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16177214.001).
  • [ISSN] 0022-3166
  • [Journal-full-title] The Journal of nutrition
  • [ISO-abbreviation] J. Nutr.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Vitamins; 01YAE03M7J / beta Carotene
  •  go-up   go-down


57. Vieth M, Behrens H, Stolte M: Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment. Gut; 2006 Aug;55(8):1151-5
MedlinePlus Health Information. consumer health - Ulcerative Colitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sporadic adenoma in ulcerative colitis: endoscopic resection is an adequate treatment.
  • BACKGROUND AND AIMS: In studies with small numbers of cases, it has been shown that endoscopic resection of adenomas in ulcerative colitis represents adequate treatment.
  • In a larger study cohort with more prolonged follow up, we assessed the reliability of this finding.
  • METHODS: Between 1988 and 2002, 148 consecutive patients, mainly from private gastroenterologists' practices, with ulcerative colitis were diagnosed as having an adenoma.
  • RESULTS: Among 60 patients, surprisingly without endoscopic treatment, 48.3% developed ulcerative colitis associated neoplasia in the same colon segment (23.3% low grade intraepithelial neoplasia; 8.3% high grade intraepithelial neoplasia; 16.7% carcinoma).
  • Among 87 patients undergoing polypectomy of the adenoma, follow up revealed colitis associated neoplasia in other segments of colon in 4.6% of cases.
  • CONCLUSION: Development of adenocarcinomas in a total of 6.7% of the overall patient group, and in 2.3% of those undergoing polypectomy, indicates that biopsy based diagnosis of an adenoma in ulcerative colitis must be considered to mandate endoscopic resection of the lesion; 40% of affected patients did not receive any form of endoscopic removal of the lesion.
  • Although polypectomy of the adenoma represents adequate therapy, further regular follow up examinations are nevertheless necessary.
  • [MeSH-major] Adenoma / etiology. Colitis, Ulcerative / complications. Colonic Neoplasms / etiology. Colonoscopy
  • [MeSH-minor] Adenocarcinoma / etiology. Aged. Biopsy. Carcinoma in Situ / etiology. Colectomy. Disease Progression. Female. Follow-Up Studies. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Ulcerative Colitis.
  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Inflamm Bowel Dis. 1999 Nov;5(4):304-5 [10579125.001]
  • [Cites] Endoscopy. 2004 Dec;36(12):1109-14 [15578305.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1295-300 [10579970.001]
  • [Cites] Hum Pathol. 2000 Mar;31(3):288-91 [10746669.001]
  • [Cites] Pathologe. 2003 Feb;24(1):36-43 [12601476.001]
  • [Cites] Gastroenterology. 2003 Apr;124(4):880-8 [12671882.001]
  • [Cites] Gastroenterology. 2004 Jan;126(1):376-8 [14753220.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Jul;2(7):534-41 [15224277.001]
  • [Cites] Am J Gastroenterol. 2004 Jul;99(7):1371-85 [15233681.001]
  • [Cites] Gastroenterology. 2004 Sep;127(3):706-13 [15362025.001]
  • [Cites] Pathol Annu. 1981;16 Pt 1:181-213 [7329731.001]
  • [Cites] Gut. 1992 May;33(5):663-7 [1612484.001]
  • [Cites] Z Gastroenterol. 1993 Nov;31(11):653-6 [8291276.001]
  • [Cites] Gastroenterology. 1994 Oct;107(4):934-44 [7926483.001]
  • [Cites] Gastroenterology. 1995 May;108(5):1361-70 [7729627.001]
  • [Cites] Am J Gastroenterol. 1997 Nov;92(11):2094-8 [9362200.001]
  • [Cites] Am J Surg Pathol. 1998 Mar;22(3):275-84 [9500769.001]
  • [Cites] Hum Pathol. 1998 Sep;29(9):961-4 [9744312.001]
  • [Cites] Am J Gastroenterol. 1999 Jul;94(7):1746-50 [10406230.001]
  • [Cites] Am J Surg Pathol. 1999 Aug;23(8):963-9 [10435567.001]
  • [Cites] Hum Pathol. 1999 Aug;30(8):898-905 [10452501.001]
  • [Cites] Gastroenterology. 1999 Dec;117(6):1288-94; discussion 1488-91 [10579969.001]
  • (PMID = 16423892.001).
  • [ISSN] 0017-5749
  • [Journal-full-title] Gut
  • [ISO-abbreviation] Gut
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1856275
  •  go-up   go-down


58. Ors F, Lev-Toaff A, O'Kane P, Qazi N, Bergin D: Paraovarian adrenal rest with MRI features characteristic of an adrenal adenoma. Br J Radiol; 2007 Sep;80(957):e205-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraovarian adrenal rest with MRI features characteristic of an adrenal adenoma.
  • Both of these MR characteristics are typically seen with an adrenal adenoma.
  • [MeSH-major] Adrenal Rest Tumor / diagnosis. Fallopian Tube Neoplasms / diagnosis
  • [MeSH-minor] Adenoma / diagnosis. Adenoma / ultrasonography. Adrenal Gland Neoplasms / diagnosis. Adrenal Gland Neoplasms / ultrasonography. Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17928489.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


59. Wang Y, Li Y, Zhang WY, Xia QJ, Li HG, Wang R, Yang L, Sun XF, Zhou ZG: mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma. Eur J Cancer Prev; 2009 Feb;18(1):40-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma.
  • As proliferation is essential for progression from normal cells to tumor, certain markers specific to proliferating cells may permit detection of premalignant lesions.
  • Here, we aimed to evaluate the possible value of a proliferation marker, minichromosome maintenance 2 (MCM2), in the early diagnosis of colorectal cancer, by analyzing the difference in MCM2 expression among normal mucosa, adenoma, and adenocarcinoma, and investigating the relationship of MCM2 expression in adenomas with clinicopathologic variables.
  • Using immunohistochemistry and real-time reverse transcription-PCR, we observed that the expression of MCM2 protein was present on basal third to half of colonic crypts in normal mucosa, whereas throughout the epithelium in adenomas and adenocarcinomas, the expression of MCM2 mRNA in adenocarcinomas was significantly higher than in adenomas (P=0.001), whereas the difference between adenoma and normal mucosa was not significant (P=0.184); we also found that the expression of MCM2 mRNA tended to be increased in the adenomas with high-grade dysplasia, or in older patients, respectively, compared with those with low-grade dysplasia, and younger patients.
  • [MeSH-major] Adenocarcinoma / genetics. Adenoma / genetics. Cell Cycle Proteins / genetics. Colonic Neoplasms / genetics. Nuclear Proteins / genetics
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / analysis. Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. Case-Control Studies. Early Detection of Cancer. Feasibility Studies. Feces / chemistry. Gene Expression Regulation, Neoplastic. Humans. Middle Aged. Minichromosome Maintenance Complex Component 2. RNA, Messenger / analysis. RNA, Messenger / isolation & purification. RNA, Messenger / metabolism. Sensitivity and Specificity. Software. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19077563.001).
  • [ISSN] 1473-5709
  • [Journal-full-title] European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
  • [ISO-abbreviation] Eur. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Cell Cycle Proteins; 0 / Nuclear Proteins; 0 / RNA, Messenger; EC 3.6.4.12 / MCM2 protein, human; EC 3.6.4.12 / Minichromosome Maintenance Complex Component 2
  •  go-up   go-down


60. Melle C, Ernst G, Schimmel B, Bleul A, Mothes H, Kaufmann R, Settmacher U, Von Eggeling F: Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma. Int J Oncol; 2006 Jan;28(1):195-200
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma.
  • The aim of the study was to detect proteomic markers usable to distinguish colorectal carcinoma from colon adenoma for a better understanding of the molecular mechanisms in the process of tumourigenesis.
  • Therefore, we microdissected colon carcinoma tissue, epithelial colon adenoma tissue as well as normal adjacent colon epithelium and determined protein profiles by SELDI-TOF MS.
  • [MeSH-major] Adenoma / genetics. Carcinoma / genetics. Colorectal Neoplasms / genetics. Gene Expression Profiling / methods. S100 Proteins / biosynthesis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16327996.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Genetic Markers; 0 / S100 Proteins; 146909-89-9 / S100A11 protein, human
  •  go-up   go-down


61. Kummerfeld M, Knieriem A, Wohlsein P: [Osteomyelitis and papillary renal adenoma in a red panda (Ailurus fulgens fulgens)]. Dtsch Tierarztl Wochenschr; 2008 Nov;115(11):421-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Osteomyelitis and papillary renal adenoma in a red panda (Ailurus fulgens fulgens)].
  • [Transliterated title] Osteomyelitis und papilläres renales Adenom bei einem Kleinen Pandabären (Ailurus fulgens fulgens).
  • Additionally, in the kidney a papillary renal adenoma was found.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19024549.001).
  • [ISSN] 0341-6593
  • [Journal-full-title] DTW. Deutsche tierärztliche Wochenschrift
  • [ISO-abbreviation] DTW. Dtsch. Tierarztl. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


62. Shivaprakash HN, Jayashree K, Girish M: Villous adenoma: a rare tumor of vaginal vault. Indian J Pathol Microbiol; 2008 Apr-Jun;51(2):265-6
MedlinePlus Health Information. consumer health - Vaginal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Villous adenoma: a rare tumor of vaginal vault.
  • Villous adenomas are extremely rare tumors in the vagina and are indistinguishable from their colonic counterparts.
  • We present a case of villous adenoma of vaginal vault, a rare site of presentation in a 30-year-old female.
  • [MeSH-major] Adenoma, Villous / pathology. Vaginal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18603704.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


63. Lü BJ, Cui J, Xu J, Zhang H, Luo MJ, Zhu YM, Lai MD: [Bioinformatic analysis of adenoma-normal mucosa SSH library of colon]. Yi Chuan; 2006 Apr;28(4):385-92
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bioinformatic analysis of adenoma-normal mucosa SSH library of colon].
  • We established a colonic adenoma-normal mucosa suppressive subtraction hybridization (SSH) library in 1999.
  • Both genes were up-regulated in 10 or 9 out of 10 adenomas in comparison with the paired normal mucosa, respectively.
  • The candidate genes in A-N library would be of great significance in disclosing the molecular mechanism underlying in colonic adenoma initiation and progression.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16606587.001).
  • [ISSN] 0253-9772
  • [Journal-full-title] Yi chuan = Hereditas
  • [ISO-abbreviation] Yi Chuan
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


64. Atabek ME, Pirgon O, Sert A, Esen HH: Extensive brown tumors caused by parathyroid adenoma in an adolescent patient. Eur J Pediatr; 2008 Jan;167(1):117-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extensive brown tumors caused by parathyroid adenoma in an adolescent patient.
  • Primary hyperparathyroidism is a rare endocrine disease in children and young adults.
  • The early detection and treatment of primary hyperparathyroidism led to a marked decrease in classical bone and renal manifestations of the disease.
  • Moreover, the skeletal involvement in primary hyperparathyroidism secondary to parathyroid adenoma is extremely rare.
  • We report on an adolescent girl with multiple brown tumors and a history of recurrent fractures as the manifestation of primary hyperparathyroidism associated with a parathyroid adenoma.
  • She had a large tumor associated with marked elevation in the parathyroid hormone and serum calcium levels.
  • Skeletal manifestations were also atypical for benign primary hyperparathyroidism, with widespread brown tumors in the patient.
  • [MeSH-major] Adenoma / complications. Hyperparathyroidism, Primary / etiology. Osteitis Fibrosa Cystica / etiology. Parathyroid Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17273830.001).
  • [ISSN] 1432-1076
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Parathyroid Hormone
  •  go-up   go-down


65. Teschner M, Buhr T, Donnerstag F, Lenarz T, Majdani O: [Expansion of an ceruminous adenoma into the middle ear]. Laryngorhinootologie; 2006 Jun;85(6):444-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expansion of an ceruminous adenoma into the middle ear].
  • Pathohistology revealed a ceruminal gland adenoma.
  • They are a rare phenomenon and should be distinguished from middle ear adenomas, pleomorph ceruminal gland adenomas, ceruminal gland adenocarcinomas and cylindromas of the ceruminal glands.
  • Despite its rare occurrence, a ceruminal gland adenoma must be taken into consideration in the differential diagnosis of individual cholesteatoma cases.
  • [MeSH-major] Adenoma / diagnosis. Apocrine Glands / pathology. Carcinoma, Squamous Cell / diagnosis. Cerumen. Ear Canal / pathology. Ear Neoplasms / diagnosis. Ear, Middle / pathology. Sweat Gland Neoplasms / diagnosis
  • [MeSH-minor] Adult. Connective Tissue / pathology. Connective Tissue / surgery. Diagnosis, Differential. Female. Hearing Loss, Mixed Conductive-Sensorineural / diagnosis. Hearing Loss, Mixed Conductive-Sensorineural / surgery. Humans. Image Enhancement. Image Processing, Computer-Assisted. Imaging, Three-Dimensional. Magnetic Resonance Imaging. Mastoid / pathology. Mastoid / surgery. Neoplasm Invasiveness. Tomography, X-Ray Computed. Tympanic Membrane Perforation / diagnosis. Tympanic Membrane Perforation / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16770841.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


66. Kaushal DK, Mishra A, Mittal N, Bordoloi JK: Successful removal of intrathyroidal parathyroid adenoma diagnosed and accurately located preoperatively by parathyroid scintigraphy (SPECT-CT). Indian J Nucl Med; 2010 Apr;25(2):62-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful removal of intrathyroidal parathyroid adenoma diagnosed and accurately located preoperatively by parathyroid scintigraphy (SPECT-CT).
  • We describe the case of a large intrathyroidal parathyroid adenoma in a 46-year-old woman who had a history of recently diagnosed hypercalcaemia and a 2-year history of an asymptomatic enlargement of the right lobe of the thyroid.
  • We present a case in which, with parathyroid scintigraphy and combination of structural and functional imaging (SPECT-CT), we could accurately locate the intrathyroidal parathyroid adenoma in a patient with multinodular goiter.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21188066.001).
  • [ISSN] 0974-0244
  • [Journal-full-title] Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
  • [ISO-abbreviation] Indian J Nucl Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3003286
  • [Keywords] NOTNLM ; Intrathyroidal parathyroid adenoma
  •  go-up   go-down


67. Juco J, Horvath E, Smyth H, Rotondo F, Kovacs K: Hemangiopericytoma of the sella mimicking pituitary adenoma: case report and review of the literature. Clin Neuropathol; 2007 Nov-Dec;26(6):288-93
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hemangiopericytoma of the sella mimicking pituitary adenoma: case report and review of the literature.
  • OBJECTIVE: Hemangiopericytoma (HPC) is a potentially malignant vascular neoplasm that in rare cases presents as a primary intracranial lesion, where most often it is meningeal in origin.
  • Often, these cases can mimic and be mistaken for a pituitary adenoma.
  • MATERIAL AND METHODS: We report a case of an 18-year-old woman presenting with a sellar mass which was thought both clinically and radiologically to be a pituitary adenoma.
  • [MeSH-major] Adenoma / diagnosis. Bone Neoplasms / diagnosis. Hemangiopericytoma / diagnosis. Pituitary Neoplasms / diagnosis. Sella Turcica / pathology

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18232595.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 22
  •  go-up   go-down


68. Ihrler S, Weiler C, Hirschmann A, Sendelhofert A, Lang S, Guntinas-Lichius O, Arnold G, Zietz C, Harrison JD: Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53. Histopathology; 2007 Sep;51(3):362-71
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraductal carcinoma is the precursor of carcinoma ex pleomorphic adenoma and is often associated with dysfunctional p53.
  • AIMS: Although intraductal carcinoma has been demonstrated in intracapsular carcinoma ex pleomorphic adenoma (CEPA), the morphological and genetic stages of transformation of pleomorphic adenoma (PA) to CEPA are not fully understood.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Carcinoma, Intraductal, Noninfiltrating / pathology. Salivary Gland Neoplasms / pathology. Salivary Glands, Minor / pathology. Tumor Suppressor Protein p53 / analysis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. DNA Mutational Analysis. Disease Progression. Female. Humans. Immunohistochemistry. Keratin-14 / analysis. Keratin-7 / analysis. Ki-67 Antigen / analysis. Male. Middle Aged. Models, Biological. Mutation

  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17593217.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Keratin-14; 0 / Keratin-7; 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


69. Sarma DP, Stevens T: Infiltrating syringomatous eccrine adenoma of the nipple: a case report. Cases J; 2009;2:9118

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infiltrating syringomatous eccrine adenoma of the nipple: a case report.
  • A biopsy revealed an infiltrating adnexal neoplasm with features similar to those seen in syringomas commonly occurring in locations such as upper face and pubis.
  • The infiltrating syringomatous adenoma of the nipple occurs almost exclusively in women of all ages and is cured by simple excision.
  • Microscopic appearance of such a rare benign infiltrating neoplasm of eccrine duct origin occurring in woman's breast should not be misinterpreted as more common infiltrating primary breast carcinoma.
  • CONCLUSION: Infiltrating eccrine syringomatous adenoma should be included in the differential diagnosis of a nipple or subareolar nodule occurring in woman.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Gynecol Obstet. 1966 Jun;122(6):1289-94 [5941852.001]
  • [Cites] Breast J. 2004 Sep-Oct;10(5):443-7 [15327500.001]
  • [Cites] Am J Surg Pathol. 1983 Dec;7(8):739-45 [6660349.001]
  • [Cites] Clin Radiol. 1993 Jan;47(1):62-4 [8381340.001]
  • [Cites] Arch Pathol Lab Med. 2003 Mar;127(3):e155-6 [12653606.001]
  • (PMID = 20062695.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2803915
  •  go-up   go-down


70. Chen HH, Lee LY, Chin SC, Chen IH, Liao CT, Huang SF: Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion. World J Surg Oncol; 2010;8:24
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion.
  • BACKGROUND: Carcinoma ex pleomorphic adenoma (CXPA) is an aggressive salivary gland malignancy and rare in minor salivary gland.
  • CASE PRESENTATION: A 60-year-old male had a 3-month history of a small soft palatal mass with progressing left cheek numbness, proptosis, and disturbed vision.
  • Biopsy of soft palatal tumor showed pleomorphic adenoma.
  • Magnetic resonance imaging showed a tumor involving left maxilla, and extended from pterygopalatine fossa, inferior orbital fissure to CS.
  • Excision of tumor revealed CXPA.
  • The tumor recurred 5 months later in left CS which was re-treated with CCRT.
  • The disease status was stable at 2 years after the diagnosis of CXPA.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Brain Neoplasms / pathology. Cavernous Sinus / pathology. Maxillary Sinus Neoplasms / pathology. Neoplasm Recurrence, Local / pathology. Palatal Neoplasms / pathology. Palate, Soft / pathology
  • [MeSH-minor] Combined Modality Therapy. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 2008 May;29(5):865-7 [18272554.001]
  • [Cites] J Korean Med Sci. 1997 Feb;12(1):63-6 [9142663.001]
  • [Cites] Head Neck. 2001 Sep;23(9):705-12 [11505478.001]
  • [Cites] Laryngoscope. 1995 Nov;105(11):1155-60 [7475867.001]
  • [Cites] Oral Oncol. 2002 Jan;38(1):107-10 [11755829.001]
  • [Cites] Top Magn Reson Imaging. 2004 Apr;15(2):79-85 [15269610.001]
  • [Cites] Otolaryngol Head Neck Surg. 2008 May;138(5):601-5 [18439465.001]
  • [Cites] J Laryngol Otol. 1995 Mar;109(3):240-3 [7745345.001]
  • [Cites] Auris Nasus Larynx. 2001 Aug;28(3):279-81 [11489377.001]
  • [Cites] AJNR Am J Neuroradiol. 1998 Apr;19(4):701-6 [9576658.001]
  • [Cites] Semin Ultrasound CT MR. 1999 Jun;20(3):175-86 [10378251.001]
  • [Cites] AJNR Am J Neuroradiol. 2006 Aug;27(7):1483-5 [16908563.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):138-43 [17049183.001]
  • [Cites] Radiology. 1992 Jul;184(1):95-101 [1319079.001]
  • (PMID = 20353573.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2860350
  •  go-up   go-down


71. Bianco A, D'Ambra L, Bonfante P, Bianchi C, Magistrelli P, Berti P, Falco E: [Surgical timing in bleeding liver adenoma: case report]. G Chir; 2007 Oct;28(10):390-3
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical timing in bleeding liver adenoma: case report].
  • [Transliterated title] Timing chirurgico nell'adenoma epatico sanguinante: case report.
  • The diagnosis of liver adenoma, which etiopathogenesis most often involves a prolonged assumption of estrogen (90% of adenomas occurs in women after more than 5 years of estrogen therapy), always imposes a surgical resection.
  • The reason depend from neoplasia characteristics like the malignant evolution (4%) and the high risk of abdominal/intratumoral bleeding (30-50%), that increases during pregnancy and postpartum period.
  • The authors relate their own experience about the therapeutic strategy and surgical timing in a case of bleeding liver adenoma.
  • [MeSH-major] Adenoma / surgery. Embolization, Therapeutic. Hemorrhage / surgery. Hepatectomy. Liver Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17915055.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


72. Nielsen EH, Lindholm J, Laurberg P, Bjerre P, Christiansen JS, Hagen C, Juul S, Jørgensen J, Kruse A, Stochholm K: Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary; 2007;10(1):67-73
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function.
  • The incidence of clinically significant, nonfunctioning pituitary adenoma, requiring surgical treatment, has not been established.
  • According to previous studies, both surgery type and subsequent radiotherapy may have an impact on quality of life (QOL), and some studies have shown increased cardiovascular mortality in patients with pituitary disease.
  • We studied all patients with functionless, suprasellar pituitary adenoma who were operated on during the period 1985-1996 (N = 192; transsphenoidal surgery = 160, craniotomy = 32).
  • [MeSH-major] Adenoma / mortality. Pituitary Neoplasms / mortality

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17356906.001).
  • [ISSN] 1386-341X
  • [Journal-full-title] Pituitary
  • [ISO-abbreviation] Pituitary
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Hazra A, Fuchs CS, Chan AT, Giovannucci EL, Hunter DJ: Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. Cancer Causes Control; 2008 Nov;19(9):975-80
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.
  • We evaluated the association of a polymorphism in TCF7L2 (RS12255372) in the WNT signaling pathway, which previously has been strongly associated with risk of Type II Diabetes, with colorectal cancer (CRC) and adenoma in the prospective Nurses' Health Study (NHS) and Health Professionals Follow-up Study (HPFS) cohorts.
  • Hyperinsulinemia may be related to the risk of colon adenoma and cancer, therefore this variant associated with reduced insulin secretion would be predicted to be inversely associated with colorectal cancer.

  • Genetic Alliance. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 2006 Jul 27;25(32):4441-8 [16547505.001]
  • [Cites] N Engl J Med. 2006 Jul 20;355(3):241-50 [16855264.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2645-8 [16936216.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2649-53 [16936217.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2654-9 [16936218.001]
  • [Cites] Diabetes. 2006 Oct;55(10):2890-5 [17003358.001]
  • [Cites] Science. 2006 Oct 13;314(5797):268-74 [16959974.001]
  • [Cites] BMC Cancer. 2006;6:268 [17109766.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2408-17 [17164363.001]
  • [Cites] Diabetologia. 2007 Jan;50(1):5-7 [17102948.001]
  • [Cites] Cancer Res. 2000 Jul 15;60(14):3872-9 [10919662.001]
  • [Cites] Genes Dev. 2000 Aug 1;14(15):1837-51 [10921899.001]
  • [Cites] Science. 2004 Mar 5;303(5663):1483-7 [15001769.001]
  • [Cites] Curr Biol. 1998 May 7;8(10):573-81 [9601641.001]
  • [Cites] Science. 1998 Sep 4;281(5382):1509-12 [9727977.001]
  • [Cites] Genet Anal. 1999 Feb;14(5-6):143-9 [10084106.001]
  • [Cites] Nature. 1999 Apr 1;398(6726):422-6 [10201372.001]
  • [Cites] Cancer Res. 1999 Sep 1;59(17):4213-5 [10485457.001]
  • [Cites] Cancer Causes Control. 1999 Oct;10(5):379-86 [10530607.001]
  • [Cites] J Biol Chem. 2005 Jan 14;280(2):1457-64 [15525634.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):850-5 [15824155.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):863-70 [15824157.001]
  • [Cites] Nat Genet. 2006 Mar;38(3):320-3 [16415884.001]
  • [Cites] Endocrinology. 2006 Apr;147(4):1830-7 [16410309.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):750-5 [16614119.001]
  • [Cites] Diabetes. 2006 Sep;55(9):2640-4 [16936215.001]
  • (PMID = 18478343.001).
  • [ISSN] 0957-5243
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA87969; United States / NCI NIH HHS / CA / T-32 CA 09001-30; United States / NCI NIH HHS / CA / K07 CA107412; United States / NCI NIH HHS / CA / CA70817; United States / NCI NIH HHS / CA / CA55075; United States / NCI NIH HHS / CA / CA107412-03; United States / NCI NIH HHS / CA / K07 CA107412-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / TCF Transcription Factors; 0 / TCF7L2 protein, human; 0 / Transcription Factor 7-Like 2 Protein
  • [Other-IDs] NLM/ NIHMS124556; NLM/ PMC2719293
  •  go-up   go-down


74. Arima K, Yamakado K, Suzuki R, Matsuura H, Nakatsuka A, Takeda K, Sugimura Y: Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months. Urology; 2007 Sep;70(3):407-11
Hazardous Substances Data Bank. Corticotropin .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome: outcomes after mean follow-up of 33 months.
  • OBJECTIVES: To evaluate the feasibility, safety, and therapeutic effects of image-guided radiofrequency (RF) ablation used for the treatment of adrenocortical adenoma with Cushing syndrome.
  • METHODS: From February 2003 to May 2005, 4 consecutive patients with adrenocortical adenoma and Cushing syndrome received percutaneous RF ablation.
  • All tumors were in the left adrenal gland, with a mean tumor size of 2.7 +/- 0.6 cm (range 2.0 to 3.5).
  • Technical success was defined as disappearance of tumor enhancement on contrast-enhanced computed tomography imaging acquired within 1 week after RF ablation.
  • RESULTS: Tumor enhancement disappeared after initial RF ablation in 3 of 4 patients (technical success rate 75%).
  • The fourth patient underwent a repeat RF ablation session 3 years later, resulting in eradication of tumor enhancement.
  • CONCLUSIONS: Using RF ablation for adrenocortical adenoma with Cushing syndrome is a feasible, safe, and promising treatment method in selected patients.
  • [MeSH-major] Adenoma / surgery. Adrenal Cortex Neoplasms / surgery. Catheter Ablation / methods. Cushing Syndrome / surgery. Fluoroscopy / methods. Radiography, Interventional / methods. Surgery, Computer-Assisted / methods

  • Genetic Alliance. consumer health - Cushing's Syndrome.
  • MedlinePlus Health Information. consumer health - Cushing's Syndrome.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17905083.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 9002-60-2 / Adrenocorticotropic Hormone; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


75. Schulz HU, Kellner U, Kahl S, Effenberger O, Asperger W, Lippert H, Röcken C: A giant pancreatic serous microcystic adenoma with 20 years follow-up. Langenbecks Arch Surg; 2007 Mar;392(2):209-13
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for microcystic adenoma .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A giant pancreatic serous microcystic adenoma with 20 years follow-up.
  • We followed up a white woman with a giant serous microcystic adenoma over more than 20 years.
  • Finally, the initial biopsy specimen was re-evaluated, using immunohistochemistry, and the final diagnosis of a serous microcystic adenoma was made.
  • CONCLUSION: This unique case demonstrates that the spontaneous course of serous microcystic adenoma of the pancreas may be favourable even with huge tumour size and that immunohistochemistry may prove a valuable tool for differential diagnosis of cystic pancreatic lesions.
  • Due to their size and progressive, space-occupying growth, these biologically benign tumours may cause injury to adjacent organs and thus clinical symptoms.

  • Genetic Alliance. consumer health - Pancreatic adenoma.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17235583.001).
  • [ISSN] 1435-2443
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 30
  •  go-up   go-down


76. Guerrero CA, Krayenbühl N, Husain M, Krisht AF: Ectopic suprasellar growth hormone-secreting pituitary adenoma: case report. Neurosurgery; 2007 Oct;61(4):E879; discussion E879
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ectopic suprasellar growth hormone-secreting pituitary adenoma: case report.
  • OBJECTIVE: Ectopic pituitary adenomas are rare.
  • We present an unusual case of an ectopic growth hormone-secreting pituitary adenoma in the suprasellar space.
  • Magnetic resonance imaging scans revealed a suprasellar mass not arising from the normal looking pituitary gland.
  • INTERVENTION: The patient underwent gross total removal of the tumor through a pterional approach.
  • Histological examination showed a growth hormone-secreting pituitary adenoma CONCLUSION: Although uncommon, growth hormone-secreting pituitary adenomas are encountered in the suprasellar region.
  • [MeSH-major] Adenoma / radiography. Choristoma. Growth Hormone-Secreting Pituitary Adenoma / radiography


77. Rembao-Bojórquez D, Vega R, Bermúdez-Maldonado L, Gutiérrez R, Salinas C, Tena-Suck M: Choroid plexus acinar adenoma: a case report. J Neurooncol; 2007 Jun;83(2):191-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Choroid plexus acinar adenoma: a case report.
  • Mucus-secreting adenomas or acinar adenoma of the choroid plexus are very rare.
  • We report the case of a 79-year-old male with a 3-year history of occipital headaches with vomiting, ataxia and cerebellar signs.
  • He was admitted to the hospital with significant tumor expansion and clinical deterioration.
  • Pathological findings were consistent with an acinar choroid plexus adenoma.
  • The tumor was attached to the ependymal lining and was strongly adhered to the walls and floor of the IV ventricle.
  • Post-operative bleeding complicated partial removal of this tumor.
  • [MeSH-major] Adenoma / pathology. Carcinoma, Acinar Cell / pathology. Cerebral Ventricle Neoplasms / pathology. Choroid Plexus Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17406790.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


78. Wang BB, Pan QH, Zhang YF, Xu YZ, Wu QG, Zhou FS, Yu GY, Sun KH, Peng X, Wu JG: [Application of fourier transform infrared spectroscopy to non-invasive detection of pleomorphic adenoma of salivary gland in vivo]. Guang Pu Xue Yu Guang Pu Fen Xi; 2007 Dec;27(12):2427-31
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Application of fourier transform infrared spectroscopy to non-invasive detection of pleomorphic adenoma of salivary gland in vivo].
  • In the present work, 20 patients with salivary pleomorphic adenoma were recruited for FTIR spectroscopic measurement.
  • It was found that there were significant differences in the spectral features of the skin covering normal salivary gland, pleomorphic adenoma, and carcinoma change of pleomorphic adenoma, such as the changes in peak position, band shape and relative intensity of the bands in the ranges of 1000-1800 cm(-1) and 2800-3000 cm(-1).
  • Pathological diagnosis demonstrated that 2 of the 20 patients suffered actually carcinoma change of pleomorphic adenoma, which is in good agreement with the result of FTIR spectroscopicmeasurement.
  • FTIR spectroscopic m ethodsuggested that pleomorphic adenoma is the intermediate between normal salivary gland and carcinoma change of pleomorphic adenoma.
  • [MeSH-major] Adenoma, Pleomorphic / chemistry. Salivary Gland Neoplasms / chemistry. Spectroscopy, Fourier Transform Infrared / methods

  • Genetic Alliance. consumer health - Salivary gland adenoma, pleomorphic.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18330277.001).
  • [ISSN] 1000-0593
  • [Journal-full-title] Guang pu xue yu guang pu fen xi = Guang pu
  • [ISO-abbreviation] Guang Pu Xue Yu Guang Pu Fen Xi
  • [Language] chi
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


79. Zan E, Limb CJ, Koehler JF, Yousem DM: Middle ear adenoma: a challenging diagnosis. AJNR Am J Neuroradiol; 2009 Sep;30(8):1602-3
MedlinePlus Health Information. consumer health - CT Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Middle ear adenoma: a challenging diagnosis.
  • Middle ear adenomas are rare benign tumors, which can easily be mistaken for other conditions radiologically.
  • We report the case of a 48-year-old man with a history of decreased left-sided hearing and intermittent pulsatile tinnitus.
  • Surgical excision revealed a middle ear adenoma.
  • [MeSH-major] Adenoma / radiography. Ear Neoplasms / radiography. Ear, Middle / radiography. Hearing Loss / diagnosis. Hearing Loss / etiology. Soft Tissue Neoplasms / radiography. Tomography, X-Ray Computed / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19369616.001).
  • [ISSN] 1936-959X
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Matsuda K, Kousaka Y, Nagamine N, Tsunoda N, Taniyama H: Papillary renal adenoma of distal nephron differentiation in a horse. J Vet Med Sci; 2007 Jul;69(7):763-5
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary renal adenoma of distal nephron differentiation in a horse.
  • From these results, this case was diagnosed as papillary renal adenoma of distal nephron differentiation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17675811.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


81. Moshkin O, Scheithauer BW, Syro LV, Velasquez A, Horvath E, Kovacs K: Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report. Endocr Pathol; 2009;20(1):50-5
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report.
  • Collision tumors of the sella turcica are rare and consist mainly of more than one type of pituitary adenoma, usually a corticotropin- and a prolactin-producing adenoma.
  • The association of a craniopharyngioma and a pituitary adenoma is rare.
  • Herein, we report the first case of an association between craniopharyngioma and silent pituitary adenoma subtype 3.
  • It involved a 12-year-old boy who underwent a frontal craniotomy with surgical removal of a calcified sellar tumor.
  • Histology revealed an adamantinomatous craniopharyngioma; however, by electron microscopy, there was conclusive evidence of adenoma cells showing the ultrastructural features of silent pituitary adenoma subtype 3.
  • [MeSH-major] Adenoma / ultrastructure. Craniopharyngioma / ultrastructure. Neoplasms, Multiple Primary / pathology. Pituitary Neoplasms / ultrastructure

  • Genetic Alliance. consumer health - Craniopharyngioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19238590.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


82. Hewett DG, Rex DK: Cap-fitted colonoscopy: a randomized, tandem colonoscopy study of adenoma miss rates. Gastrointest Endosc; 2010 Oct;72(4):775-81
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cap-fitted colonoscopy: a randomized, tandem colonoscopy study of adenoma miss rates.
  • BACKGROUND: Failures of adenoma detection diminish the effectiveness of colonoscopy.
  • OBJECTIVE: This study investigated the impact of cap-fitted colonoscopy (CFC) on the adenoma miss rate at colonoscopy.
  • MAIN OUTCOME MEASUREMENTS: The primary outcome measure was the miss rate for adenomas between patients who underwent CFC first and patients who underwent regular colonoscopy first.
  • RESULTS: A total of 238 adenomas were detected in 67 patients (67%), with a combined overall miss rate of 27.7%, comprising 66 missed adenomas in 38 patients.
  • Patients undergoing initial CFC had a significantly lower miss rate for all adenomas compared with that of patients undergoing regular colonoscopy (21% vs 33%, P = .039).
  • Miss rates with CFC were significantly lower for adenomas of ≤5 mm (22% vs 35%; P = .037).
  • CONCLUSION: CFC reduces miss rates for all adenomas and specifically for small adenomas. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT00577083).
  • [MeSH-major] Adenoma / diagnosis. Colonic Neoplasms / diagnosis. Colonoscopy / methods. Diagnostic Errors / statistics & numerical data

  • MedlinePlus Health Information. consumer health - Colonoscopy.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
  • [CommentIn] Gastrointest Endosc. 2010 Oct;72(4):782-3 [20883855.001]
  • (PMID = 20579648.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00577083
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


83. Kurome M, Kato J, Nawa T, Fujimoto T, Yamamoto H, Shiode J, Wato M, Kuwaki K, Okada H, Sakaguchi K, Shiratori Y: Risk factors for high-grade dysplasia or carcinoma in colorectal adenoma cases treated with endoscopic polypectomy. Eur J Gastroenterol Hepatol; 2008 Feb;20(2):111-7
MedlinePlus Health Information. consumer health - Colorectal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk factors for high-grade dysplasia or carcinoma in colorectal adenoma cases treated with endoscopic polypectomy.
  • OBJECTIVE: Our aim is to establish the risk factors for carrying high-grade dysplasia or carcinoma by analyzing endoscopically treated adenoma cases.
  • RESULTS: A total of 889 patients (mean age: 63+/-11 years), and 1486 adenomas resected from these patients, were included in the analysis.
  • Seventy-five adenomas (5%) from 72 patients (8%) were found to have high-grade dysplasia or carcinoma.
  • Among patient factors, female sex [odds ratio (OR) 2.25, 95% confidence intervals (CI)=1.34-3.76], presence of multiple adenomas (OR=2.15, 95% CI=1.15-4.00), older age (OR=1.02, 95% CI=1.00-1.04), and rectal bleeding as the indication for colonoscopy (OR=2.57, 95% CI=1.34-4.92) were identified as the significant risk factors for carrying high-grade dysplasia or carcinoma using the multivariate analysis.
  • In addition, a size of > or = 10 mm (OR=10.83, 95% CI=5.86-20.0), flat appearance (OR=3.91, 95% CI=2.20-6.95), and location on the left side of the colon (OR=1.80, 95% CI=1.03-3.13) were identified as tumor risk factors.
  • Moreover, female sex as a risk factor raises an interesting problem regarding the progression from adenoma to carcinoma.
  • [MeSH-major] Adenoma / pathology. Colonic Polyps / pathology. Colorectal Neoplasms / pathology
  • [MeSH-minor] Age Factors. Aged. Colonoscopy. Disease Progression. Female. Humans. Male. Middle Aged. Risk Factors. Sex Factors

  • MedlinePlus Health Information. consumer health - Colonic Polyps.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18188030.001).
  • [ISSN] 0954-691X
  • [Journal-full-title] European journal of gastroenterology & hepatology
  • [ISO-abbreviation] Eur J Gastroenterol Hepatol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  •  go-up   go-down


84. Kimura M, Irie A, Minei S, Ishii J, Okawa A, Takashima R, Kadowaki K, Morinaga S, Baba S: [A case of adrenocortical adenoma coexisting with gastrointestinal stromal tumor]. Hinyokika Kiyo; 2007 Aug;53(8):551-5
MedlinePlus Health Information. consumer health - Stomach Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of adrenocortical adenoma coexisting with gastrointestinal stromal tumor].
  • A 48-year-old man was referred to our institute for the evaluation of a concomitant gastric submucosal tumor and right adrenal tumor, incidentally found by ultrasound examination.
  • Computed tomography showed a mass with a diameter of 6 cm adjacent to the stomach and the right adrenal tumor with a diameter of 3 cm.
  • By magnetic resonance imaging, the intensity of the right adrenal tumor was equivalent to the liver in both T1 and T2 weighted images.
  • On the other hand, the gastric submucosal tumor showed low intensity in T1 weighted images and high intensity in T2 weighted images.
  • An adosterol scintigram showed slight accumulation at the region of adrenal tumor.
  • Pathological diagnosis of the adrenal tumor was a cortical adenoma, and that of the gastric submucosal tumor was gastrointestinal stromal tumor (GIST).
  • The gastric tumor was immunohistochemically stained positive with the C-kit and CD34 and negative for s-100 protein and desmin.
  • Histopathological diagnosis was coincident with gastric GIST and right adrenocortical adenoma, and the GIST was diagnosed as a high risk tumor because its diameter was over 5 cm.
  • [MeSH-major] Adrenal Cortex Neoplasms / surgery. Adrenocortical Adenoma / surgery. Gastrointestinal Stromal Tumors / surgery. Laparoscopy. Stomach Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17874546.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


85. Ward MH, Cross AJ, Divan H, Kulldorff M, Nowell-Kadlubar S, Kadlubar FF, Sinha R: Processed meat intake, CYP2A6 activity and risk of colorectal adenoma. Carcinogenesis; 2007 Jun;28(6):1210-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Processed meat intake, CYP2A6 activity and risk of colorectal adenoma.
  • Red and processed meat intake is associated with increased risks of both colorectal adenoma and cancer.
  • Processed meats contain nitrate and nitrite, precursors of N-nitroso compounds (NOCs); furthermore, meats cooked at high temperatures contain heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs).
  • We conducted a case-control study of 146 cases of colorectal adenoma, diagnosed at sigmoidoscopy or colonoscopy, and 228 polyp-free controls.
  • Our results suggest that nitrite and nitrate intake from processed meat intake increases the risk of colorectal adenoma after accounting for HCA and PAH.
  • [MeSH-major] Adenoma / enzymology. Aryl Hydrocarbon Hydroxylases / physiology. Colorectal Neoplasms / enzymology. Diet. Meat Products. Mixed Function Oxygenases / physiology

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17277235.001).
  • [ISSN] 0143-3334
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CYP2A6 protein, human; EC 1.- / Mixed Function Oxygenases; EC 1.14.13.- / Cytochrome P-450 CYP2A6; EC 1.14.14.1 / Aryl Hydrocarbon Hydroxylases
  •  go-up   go-down


86. Wang KL, Weinrach DM, Luan C, Han M, Lin F, Teh BT, Yang XJ: Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol; 2007 Feb;38(2):239-46
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
  • The purpose of this study is to determine the incidence, histomorphological features, and immunohistochemical features of papillary adenoma and elucidate its potential relationship to RCC.
  • Thirty-eight (7%) nephrectomy specimens showed histologic evidence of papillary adenoma.
  • Seven papillary adenomas (18%) occurred in the setting of acquired polycystic kidney disease (APKD), 6 in clear-cell RCCs, 3 in chromophobe RCCs, 2 in end-stage kidney disease, 1 in oncocytoma, 1 in angiomyolipoma, and 1 in renal schwannoma.
  • Furthermore, papillary adenomas were more commonly found in kidneys removed for PRCC (25%, 18/71) than in kidneys harboring clear-cell RCC (1.9%, 6/318).
  • Histomorphologically, papillary adenomas were characterized by varying proportions of papillae and tubules formed by cuboidal cells with scant basophilic cytoplasm similar to those in type 1 PRCC.
  • Adenomas associated with PRCC tend to be multiple in number (61% [11/18] of cases had >2 adenomas; mean, 5).
  • In contrast, 100% of papillary adenomas arising in other conditions had less than 2 adenomas.
  • Most of the adenomas (82%, 31/38) stained strongly for AMACR in a fashion similar to that of PRCC.
  • In this study of surgical specimens, the high coincidence, multifocality, and histologic and immunohistochemical similarities between papillary adenoma and PRCC suggest that the 2 are strongly associated and may represent a continuum of 1 biologic process.
  • In contrast, adenomas associated with APKD exhibit distinct morphological and immunohistochemical features and, therefore, may have an entirely different pathogenesis.
  • [MeSH-minor] Adenocarcinoma, Clear Cell / enzymology. Adenocarcinoma, Clear Cell / pathology. Adenoma. Adenoma, Oxyphilic / enzymology. Adenoma, Oxyphilic / pathology. Adult. Aged. Aged, 80 and over. Angiomyolipoma / enzymology. Angiomyolipoma / pathology. Disease Progression. Female. Glutathione Transferase / analysis. Humans. Immunohistochemistry. Isoenzymes / analysis. Kidney / enzymology. Kidney / pathology. Kidney Failure, Chronic / enzymology. Kidney Failure, Chronic / pathology. Male. Middle Aged. Models, Biological. Polycystic Kidney Diseases / enzymology. Polycystic Kidney Diseases / pathology. Racemases and Epimerases / analysis

  • Genetic Alliance. consumer health - Papillary renal cell carcinoma.
  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17056094.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Isoenzymes; EC 2.5.1.18 / Glutathione Transferase; EC 2.5.1.18 / glutathione S-transferase alpha; EC 5.1.- / Racemases and Epimerases; EC 5.1.99.4 / alpha-methylacyl-CoA racemase
  •  go-up   go-down


87. Kirk J, Au-Yong I, Ganatra R: Multimodality imaging of a retrosternal parathyroid adenoma with multiple brown tumors. Clin Nucl Med; 2009 Sep;34(9):555-9
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multimodality imaging of a retrosternal parathyroid adenoma with multiple brown tumors.
  • Brown tumors of hyperparathyroidism are rare but can mimic metastatic disease on many imaging modalities.
  • We report the case of a patient presenting with symptomatic brown tumors of hyperparathyroidism due to a large retrosternal parathyroid adenoma, with histopathological correlation of both.
  • The initial imaging findings on plain radiography, computed tomography, and bone scintigraphy were nonspecific and difficult to differentiate from the more common diagnosis of metastatic disease.
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Hyperparathyroidism / complications. Hyperparathyroidism / radiography. Hyperparathyroidism / ultrasonography. Thyroid Gland / radiography. Thyroid Gland / ultrasonography. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19692812.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Siezen CL, van Leeuwen AI, Kram NR, Luken ME, van Kranen HJ, Kampman E: Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis; 2005 Feb;26(2):449-57
Pharmacogenomics Knowledge Base. meta-databases - Pharmacogenomic Annotation 827853790 for PMID:15550453 [PharmGKB] .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.
  • Associations between polymorphisms in genes (SNPs) involved in the arachidonic acid (AA) pathway and colorectal adenomas have been investigated in a Dutch case control study including 384 cases and 403 polyp-free controls.
  • A protective effect on colorectal adenomas was found for the CT genotype of SNP H477H in PPARgamma and the GC genotype of SNP V102V in COX-2 (OR 0.63, 95% CI 0.45-0.89 and OR 0.65, 95% CI 0.46-0.92, respectively) compared with the homozygous major genotypes.
  • An increase in adenoma risk was observed for the TC genotype of SNP c.2242T-->C in COX-2 (OR 1.47, 95% CI 1.07-2.00) compared with the TT genotype.
  • For SNP c.-789C-->T in PPARdelta the major genotype showed a decrease in adenoma risk for those in the highest tertile of fish consumption (T3), as compared with the lowest tertile (T1) (OR 0.65, 95% CI 0.41-1.02).
  • These results indicate that SNPs in genes involved in the AA pathway are associated with colorectal adenoma risk.
  • [MeSH-major] Adenoma / genetics. Arachidonic Acid / genetics. Diet. Fishes. Polymorphism, Single Nucleotide / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Animals. Case-Control Studies. Colorectal Neoplasms / diet therapy. Colorectal Neoplasms / genetics. Cyclooxygenase 2. Genetic Predisposition to Disease. Haplotypes. Humans. Membrane Proteins. Middle Aged. Netherlands. PPAR gamma / genetics. Prostaglandin-Endoperoxide Synthases / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15550453.001).
  • [ISSN] 0143-3334
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / PPAR gamma; 27YG812J1I / Arachidonic Acid; EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / PTGS2 protein, human; EC 1.14.99.1 / Prostaglandin-Endoperoxide Synthases
  •  go-up   go-down


89. Pitale A, Andrabi SI, Dolan SJ, Russell CF: Minimally invasive parathyroid exploration for solitary adenoma. Initial experience with an open, 'short incision' approach. Ulster Med J; 2008 May;77(2):115-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Minimally invasive parathyroid exploration for solitary adenoma. Initial experience with an open, 'short incision' approach.
  • BACKGROUND: In the vast majority of patients with primary hyperparathyroidism (HPT) the causative pathology is a benign solitary adenoma.
  • This has facilitated a focused unilateral operation to be performed in patients with a solitary parathyroid adenoma.
  • CONCLUSION: A short incision cervical approach for HPT due to solitary adenoma is a viable alternative for appropriately selected patients.
  • [MeSH-major] Adenoma / surgery. Minimally Invasive Surgical Procedures / methods. Parathyroid Neoplasms / surgery. Parathyroidectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Surg. 1999 Dec;86(12):1563-6 [10594506.001]
  • [Cites] Clin Radiol. 2001 Jul;56(7):556-9 [11446753.001]
  • [Cites] World J Surg. 2003 Mar;27(3):339-42 [12607063.001]
  • [Cites] BMJ. 2004 Apr 10;328(7444):849-50 [15073054.001]
  • [Cites] J Nucl Med. 1983 May;24(5):438-41 [6842292.001]
  • [Cites] Curr Probl Surg. 1985 Nov;22(11):1-50 [4085260.001]
  • [Cites] Br J Surg. 2006 Apr;93(4):418-21 [16392100.001]
  • [Cites] Nucl Med Commun. 1989 Nov;10(11):791-4 [2532313.001]
  • [Cites] World J Surg. 1991 Nov-Dec;15(6):688-92 [1767534.001]
  • [Cites] Ann Surg. 1992 Apr;215(4):300-17 [1558410.001]
  • [Cites] Clin Radiol. 1995 Oct;50(10):677-80 [7586958.001]
  • [Cites] Aust N Z J Surg. 1998 Feb;68(2):147-50 [9494010.001]
  • [Cites] Surgery. 1998 Dec;124(6):1077-9; discussion 1079-80 [9854586.001]
  • [Cites] J R Coll Surg Edinb. 1989 Feb;34(1):40-3 [2540329.001]
  • (PMID = 18711630.001).
  • [ISSN] 0041-6193
  • [Journal-full-title] The Ulster medical journal
  • [ISO-abbreviation] Ulster Med J
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Northern Ireland
  • [Other-IDs] NLM/ PMC2516437
  •  go-up   go-down


90. Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW: XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev; 2006 Dec;15(12):2384-90
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.
  • We have previously reported an inverse association between the XRCC1 codon 399 SNP and adenoma risk among these subjects.
  • We now report that subjects with the XPD Gln/Gln genotype were inversely associated with adenoma risk [odds ratio (OR), 0.7; 95% confidence interval (95% CI), 0.5-1.0] when compared with subjects with the Lys/Lys and Lys/Gln genotypes combined.
  • This association differed between different ethnic groups (gene x race heterogeneity likelihood ratio test, P = 0.009), with a stronger inverse association among Latinos (OR, 0.1; 95% CI, 0.01-0.5) than among non-Latinos (OR, 0.9; 95% CI, 0.-1.3).
  • Analyses ignoring XPD showed no association between alcohol intake and adenoma prevalence; however, among carriers of the codon 751 Gln/Gln genotype, we found a significant positive association (OR, 2.5; 95% CI, 1.2-5.2 for ever drinkers; test of interaction P = 0.04).
  • [MeSH-major] Adenoma / genetics. Alcohol Drinking / genetics. Colorectal Neoplasms / genetics. DNA Repair / genetics. DNA-Binding Proteins / genetics. Polymorphism, Single Nucleotide. Smoking / genetics. Xeroderma Pigmentosum Group D Protein / genetics

  • MedlinePlus Health Information. consumer health - Alcohol.
  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17164360.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 1R01CA096830; United States / NIEHS NIH HHS / ES / 5P30 ES07048
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / X-ray repair cross complementing protein 1; 0 / X-ray repair cross complementing protein 3; EC 3.6.4.12 / Xeroderma Pigmentosum Group D Protein
  •  go-up   go-down


91. Power C, Kavanagh D, Hill AD, O'Higgins N, McDermott E: Unusual presentation of a giant parathyroid adenoma: report of a case. Surg Today; 2005;35(3):235-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unusual presentation of a giant parathyroid adenoma: report of a case.
  • Parathyroid adenomas account for most cases of primary hyperparathyroidism (1 degrees HPT).
  • Certain symptoms and biochemical abnormalities alert the surgeon to their presence, since these benign tumors are rarely evident on physical examination.
  • Parathyroid adenomas rarely attain huge proportions.
  • We report a case of a parathyroid adenoma measuring 8 x 5 x 3.5 cm and weighing 110 g; to our knowledge the greatest mass reported in the literature.
  • Interestingly, despite its huge size it did not cause many of the hypercalcemic symptoms usually associated with larger adenomas, but rather it manifested with symptoms of local pressure, another unusual property of this atypical tumor.
  • [MeSH-major] Adenoma / pathology. Adenoma / surgery. Parathyroid Neoplasms / pathology. Parathyroid Neoplasms / surgery
  • [MeSH-minor] Aged. Aged, 80 and over. Biopsy, Needle. Female. Follow-Up Studies. Humans. Hyperparathyroidism / diagnosis. Hyperparathyroidism / etiology. Immunohistochemistry. Ireland. Neoplasm Staging. Parathyroidectomy / methods. Risk Assessment. Severity of Illness Index. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15772795.001).
  • [ISSN] 0941-1291
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


92. Kawai K, Sakairi T, Tanaka M, Shinozuka J, Ide M, Sato H, Fujiwara T, Sano F, Kume E: A Hepatocellular Adenoma in a Diet-induced Obese Mouse. J Toxicol Pathol; 2010 Mar;23(1):59-62

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A Hepatocellular Adenoma in a Diet-induced Obese Mouse.
  • A diagnosis of hepatocellular adenoma was made based on these findings.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22319226.001).
  • [ISSN] 1881-915X
  • [Journal-full-title] Journal of toxicologic pathology
  • [ISO-abbreviation] J Toxicol Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Other-IDs] NLM/ PMC3234647
  • [Keywords] NOTNLM ; Hepatocellular adenoma / diet-induced obese mouse / inclusion body
  •  go-up   go-down


93. Killory BD, Kresl JJ, Wait SD, Ponce FA, Porter R, White WL: Hypofractionated Cyberknife Radiosurgery for Perichiasmatic Pituitary Adenomas: Early Results. Neurosurgery; 2009 Feb 01;64(suppl_2):A19-A25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hypofractionated Cyberknife Radiosurgery for Perichiasmatic Pituitary Adenomas: Early Results.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28175597.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Pollock BE: Radiotherapy and Radiosurgery for Hormone Secreting Pituitary Adenomas. Neurosurgery; 2010 May 01;66(5):E1030

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiotherapy and Radiosurgery for Hormone Secreting Pituitary Adenomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28173407.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. Ishida M, Egawa S, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Furukawa T, Unno M: Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma. J Hepatobiliary Pancreat Surg; 2007;14(5):522-5
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
  • A 72-year-old woman, who had undergone pylorus-preserving pancreatoduodenectomy 3 years before for cancer of Vater's papilla associated with a branch-type intraductal papillary-mucinous adenoma (IPMA), developed dilatation of the main duct and a nodular lesion in the remnant pancreas.
  • Total pancreatectomy was performed, which revealed that the lesion was intraductal papillary-mucinous adenocarcinoma (IPMC) with minimal invasion, suggesting the metachronous multicentric occurrence of this intraductal papillary-mucinous neoplasm (IPMN).

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17909725.001).
  • [ISSN] 0944-1166
  • [Journal-full-title] Journal of hepato-biliary-pancreatic surgery
  • [ISO-abbreviation] J Hepatobiliary Pancreat Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


96. Kamida T, Abe T, Inoue R, Kobayashi H, Suzuki M, Matsumoto A: Stereotactic radiosurgery for recurrent pleomorphic adenoma invading the skull base--case report--. Neurol Med Chir (Tokyo); 2005 Mar;45(3):161-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stereotactic radiosurgery for recurrent pleomorphic adenoma invading the skull base--case report--.
  • A 38-year-old man presented with a recurrent pleomorphic adenoma in the parapharyngeal space invading the skull base 19 years after the first operation for a parotid gland tumor.
  • Stereotactic radiotherapy was performed to control the tumor growth using a marginal dose of 8 Gy and maximum dose of 18 Gy with care taken to minimize the dose to nearby structures.
  • Magnetic resonance imaging over 5 years showed that the tumor was controlled with no regrowth.
  • Stereotactic radiotherapy is a therapeutic option for the treatment of pleomorphic adenomas.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Adenoma, Pleomorphic / surgery. Neoplasm Recurrence, Local / pathology. Parotid Neoplasms / pathology. Radiosurgery / methods. Skull Base Neoplasms / pathology. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Hoarseness / etiology. Hoarseness / pathology. Hoarseness / physiopathology. Humans. Magnetic Resonance Imaging. Male. Neoplasm, Residual / pathology. Neoplasm, Residual / radiography. Pharynx / pathology. Salivary Glands / pathology. Treatment Outcome. Vagus Nerve Diseases / etiology. Vagus Nerve Diseases / pathology. Vagus Nerve Diseases / physiopathology. Vestibulocochlear Nerve Diseases / etiology. Vestibulocochlear Nerve Diseases / pathology. Vestibulocochlear Nerve Diseases / physiopathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15782009.001).
  • [ISSN] 0470-8105
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


97. Papanikolaou V, Giakoustidis D, Patsiaura K, Imvrios G, Antoniadis N, Ouzounidis N, Nikopolitidis V, Antoniadis A, Takoudas D: Management of a giant ruptured hepatocellular adenoma. Report of a case. Hippokratia; 2007 Apr;11(2):86-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of a giant ruptured hepatocellular adenoma. Report of a case.
  • This report describes a rare case of a young woman with massive intra-abdominal bleeding due to a giant ruptured hepatocellular adenoma.
  • After haemodynamic stabilization in the ICU and because of a complicated postoperative course (signs of intraabdominal sepsis) she was transferred to our hospital and a left lobectomy was performed.
  • We present the case and comment on the preferred treatment modalities of hepatocellular adenomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ceylon Med J. 1997 Mar;42(1):42-3 [9164033.001]
  • [Cites] Liver Transpl Surg. 1995 Mar;1(2):99-102 [9346548.001]
  • [Cites] AJR Am J Roentgenol. 1995 Dec;165(6):1426 [7484578.001]
  • [Cites] Arch Surg. 1994 Jul;129(7):712-7 [7517661.001]
  • [Cites] Br J Surg. 1993 Mar;80(3):380-3 [8472159.001]
  • [Cites] Br J Surg. 2001 Feb;88(2):207-9 [11167868.001]
  • [Cites] Ann Intern Med. 1989 Mar 15;110(6):489-90 [2537593.001]
  • [Cites] Ann Intern Med. 1986 Oct;105(4):547-9 [3019201.001]
  • [Cites] Lancet. 1980 Feb 9;1(8163):273-6 [6101735.001]
  • [Cites] Dig Surg. 2002;19(2):109-13 [11978996.001]
  • [Cites] Surg Gynecol Obstet. 1991 Nov;173(5):426-31 [1658955.001]
  • (PMID = 19582184.001).
  • [ISSN] 1790-8019
  • [Journal-full-title] Hippokratia
  • [ISO-abbreviation] Hippokratia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Other-IDs] NLM/ PMC2464268
  • [Keywords] NOTNLM ; adenoma / giant / hepatocellular / rupture / surgical
  •  go-up   go-down


98. de Maat MF, Narita N, Benard A, Yoshimura T, Kuo C, Tollenaar RA, de Miranda NF, Turner RR, van de Velde CJ, Morreau H, Hoon DS: Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. Am J Pathol; 2010 Nov;177(5):2347-56
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
  • Microsatellite instability (MSI) and genomic hypermethylation of methylated-in-tumor (MINT) loci are both strong prognostic indicators in a subgroup of patients with sporadic colorectal cancer (CRC).
  • The present study was designed to determine whether the methylation of MINT loci during the progression of adenoma to CRC is related to MSI in CRC cases.
  • Methylation index (MI) was measured by absolute quantitative assessment of methylated alleles at seven MINT loci in primary CRC with contiguous adenomatous and normal tissues of 79 patients.
  • Increased MI of both MINT loci 1 and 31 was significantly associated with MSI in CRC and was specific for adenoma.
  • Total MI and the number of methylated loci were threefold (P=0.02) and fivefold (P=0.004) higher, respectively, in adenomas associated with microsatellite-stable CRC versus microsatellite-unstable CRC.
  • MINT MI was found to be correlated with mismatch repair protein expression, MSI, BRAF (V600E) mutation status, mut-L homologue 1 methylation status, and disease-specific survival in the second independent validation group of patients.
  • MI of specific MINT loci may be prognostic indicators of colorectal adenomas that will develop into sporadic microsatellite-unstable CRCs.
  • [MeSH-major] Adenoma / genetics. Colorectal Neoplasms / genetics. DNA Methylation. Microsatellite Instability
  • [MeSH-minor] Adaptor Proteins, Signal Transducing / genetics. Aged. Aged, 80 and over. Biological Assay / methods. DNA Mismatch Repair. DNA Mutational Analysis. Disease Progression. Female. Humans. Kaplan-Meier Estimate. Male. Mutation. Nuclear Proteins / genetics. Proto-Oncogene Proteins / genetics. Proto-Oncogene Proteins B-raf / genetics. ras Proteins / genetics

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1999 Nov 1;59(21):5438-42 [10554013.001]
  • [Cites] Gut. 2009 Jan;58(1):90-6 [18832519.001]
  • [Cites] Br J Cancer. 2001 Sep 1;85(5):692-6 [11531254.001]
  • [Cites] J Pathol. 2001 Dec;195(5):543-8 [11745689.001]
  • [Cites] Lancet Oncol. 2002 Feb;3(2):83-8 [11905459.001]
  • [Cites] Gastroenterology. 2002 May;122(5):1376-87 [11984524.001]
  • [Cites] Am J Pathol. 2002 May;160(5):1823-30 [12000733.001]
  • [Cites] Cancer Res. 2002 Nov 1;62(21):6011-4 [12414620.001]
  • [Cites] Am J Pathol. 2003 Feb;162(2):469-77 [12547705.001]
  • [Cites] Am J Pathol. 2003 Mar;162(3):815-22 [12598316.001]
  • [Cites] Clin Cancer Res. 2003 Mar;9(3):1112-7 [12631615.001]
  • [Cites] Int J Cancer. 2003 Aug 10;106(1):66-73 [12794758.001]
  • [Cites] Int J Cancer. 2004 Jan 10;108(2):237-42 [14639609.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):972-80 [14871975.001]
  • [Cites] J Natl Cancer Inst. 2004 Feb 18;96(4):261-8 [14970275.001]
  • [Cites] Gut. 2004 Apr;53(4):573-80 [15016754.001]
  • [Cites] N Engl J Med. 2009 Feb 5;360(6):563-72 [19196673.001]
  • [Cites] Clin Cancer Res. 2009 Mar 1;15(5):1801-7 [19223509.001]
  • [Cites] Clin Cancer Res. 2009 Dec 1;15(23):7322-9 [19934290.001]
  • [Cites] J Mol Diagn. 2010 Jan;12(1):27-34 [19959798.001]
  • [Cites] Clin Cancer Res. 2010 Jan 1;16(1):21-33 [20028768.001]
  • [Cites] J Clin Oncol. 2010 Jan 20;28(3):466-74 [20008640.001]
  • [Cites] Gastroenterology. 2007 Jan;132(1):127-38 [17087942.001]
  • [Cites] Cancer Res. 2004 Mar 15;64(6):2245-50 [15026369.001]
  • [Cites] Cancer Biol Ther. 2004 Jan;3(1):73-8 [14726676.001]
  • [Cites] Oncogene. 2004 May 13;23(22):4014-22 [15064737.001]
  • [Cites] Am J Clin Pathol. 2004 Nov;122(5):740-6 [15491970.001]
  • [Cites] Cancer Res. 1997 Aug 15;57(16):3370-4 [9269998.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870-5 [9618505.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8698-702 [9671741.001]
  • [Cites] Cancer Res. 1998 Aug 1;58(15):3455-60 [9699680.001]
  • [Cites] Cancer Res. 1999 May 15;59(10):2307-12 [10344734.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6 [10411935.001]
  • [Cites] Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):656-63 [15701853.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Apr 1;329(1):219-23 [15721296.001]
  • [Cites] Cancer Res. 2005 Mar 1;65(5):1800-7 [15753377.001]
  • [Cites] Int J Cancer. 2005 Jul 10;115(5):747-51 [15704093.001]
  • [Cites] Int J Cancer. 2005 Oct 10;116(6):914-9 [15856472.001]
  • [Cites] Nat Clin Pract Oncol. 2005 Aug;2(8):398-405 [16130936.001]
  • [Cites] Gastroenterology. 2005 Sep;129(3):837-45 [16143123.001]
  • [Cites] Clin Cancer Res. 2005 Sep 15;11(18):6466-71 [16166421.001]
  • [Cites] Int J Cancer. 2006 Feb 15;118(4):907-15 [16152625.001]
  • [Cites] Nat Rev Cancer. 2006 Feb;6(2):107-16 [16491070.001]
  • [Cites] Mol Cancer Res. 2006 May;4(5):303-9 [16687485.001]
  • [Cites] Gut. 2006 Jul;55(7):1000-6 [16407376.001]
  • [Cites] Nat Genet. 2006 Jul;38(7):787-93 [16804544.001]
  • [Cites] J Mol Diagn. 2006 Jul;8(3):305-11 [16825502.001]
  • [Cites] Cold Spring Harb Symp Quant Biol. 2005;70:329-33 [16869769.001]
  • [Cites] Gut. 2006 Nov;55(11):1598-605 [16682430.001]
  • [Cites] Cancer Biomark. 2006;2(1-2):29-35 [17192057.001]
  • [Cites] Clin Cancer Res. 2007 Apr 1;13(7):2068-74 [17404088.001]
  • [Cites] Mol Cancer Res. 2007 May;5(5):461-71 [17510312.001]
  • [Cites] Clin Cancer Res. 2007 Oct 1;13(19):5729-35 [17908962.001]
  • [Cites] J Clin Oncol. 2007 Nov 1;25(31):4887-94 [17971584.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9 [18003927.001]
  • [Cites] N Engl J Med. 2008 Mar 13;358(11):1148-59 [18337604.001]
  • [Cites] Gastroenterology. 2008 Apr;134(4):988-97 [18395080.001]
  • [Cites] J Clin Oncol. 2008 May 10;26(14):2327-35 [18467724.001]
  • [Cites] Gastroenterology. 2008 Jun;134(7):1950-60, 1960.e1 [18435933.001]
  • [Cites] Mol Cancer. 2008;7:68 [18718023.001]
  • [Cites] Cancer Res. 2008 Oct 15;68(20):8541-6 [18922929.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):710-5 [10639144.001]
  • (PMID = 20952593.001).
  • [ISSN] 1525-2191
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / KRAS protein, human; 0 / MLH1 protein, human; 0 / Nuclear Proteins; 0 / Proto-Oncogene Proteins; EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf; EC 3.6.5.2 / ras Proteins
  • [Other-IDs] NLM/ PMC2966793
  •  go-up   go-down


99. Capussotti L, Ferrero A, Sgotto E, Viganò L, Muratore A, Polastri R: Right hepatectomy with anterior approach for ruptured liver cell adenoma. Hepatogastroenterology; 2007 Jul-Aug;54(77):1557-9
MedlinePlus Health Information. consumer health - Liver Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Right hepatectomy with anterior approach for ruptured liver cell adenoma.
  • We report a case of a 37-year-old woman who was referred to a peripheral hospital with severe abdominal pain, vomiting and hemorrhagic shock.
  • Ultrasonography and CT scan showed a large ruptured adenoma of the right liver.
  • She underwent relaparotomy and a ruptured liver cell adenoma with a huge hepatic hematoma completely involving the right liver and part of segment 4 was confirmed.
  • Considering the size of the lesion and the presence of a large hematoma, a right hepatectomy with anterior approach was performed.
  • In case of emergency liver resections, the anterior approach is preferable not only to avoid tumor manipulation and the risk of its rupture, but mainly to reduce liver bleeding and to prevent sudden fall of the blood pressure due to inferior vena cava twisting in a hemodynamically instable patient.
  • [MeSH-major] Adenoma, Liver Cell / surgery. Hepatectomy / methods. Liver Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17708298.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


100. Jayaraman M, Ambika S, Gandhi RA, Bassi SR, Ravi P, Sen P: Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma. Doc Ophthalmol; 2010 Dec;121(3):197-204
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
  • To investigate the effect of pituitary adenoma compressing the optic chiasm on multifocal visual evoked potential (mfVEP) responses and to compare these responses with visual field defects seen on static automated perimetry (SAP).
  • Eight eyes of four subjects (median age, 41.50 years; interquartile range, 33-51 years) who were diagnosed with pituitary adenoma on magnetic resonance imaging (MRI) and seen to have a bitemporal visual field defect on standard automated perimetry (SAP), and twelve age-matched normal subjects (median age, 47.00 years; interquartile range, 34.75-51.75 years) were subjected to multifocal visual evoked potential (mfVEP) testing.
  • Chiasmal compression due to pituitary adenoma causes the reduction of amplitudes and prolongation of latencies of the mfVEP response.
  • The mfVEP can be used to assess objectively the topography of the visual field in compressive optic neuropathy secondary to pituitary adenomas.
  • It can be used in assessing the subjects whose visual field report is unreliable and prolonged median latency can be an early sign of the disease.
  • [MeSH-major] Adenoma / complications. Nerve Compression Syndromes / diagnosis. Optic Chiasm. Optic Nerve Diseases / diagnosis. Pituitary Neoplasms / complications

  • MedlinePlus Health Information. consumer health - Optic Nerve Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20821036.001).
  • [ISSN] 1573-2622
  • [Journal-full-title] Documenta ophthalmologica. Advances in ophthalmology
  • [ISO-abbreviation] Doc Ophthalmol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down






Advertisement